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2. ABSTRACT 
We performed open, randomized, placebo-controlled experimental studies in intact, 
anesthetized pigs with the following main aims: 
Paper 1. 
To describe in detail the hemodynamic function with emphasis on left ventricular 
contractility during surface cooling, steady state severe hypothermia at 25°C, surface 
rewarming and in the post-hypothermic period of 2 h.   
Paper 2 
1) To investigate the pharmacokinetic properties of DA in normothermia and 
hypothermia. 
2) To carry out a detailed analysis of the cardiovascular response to incrementing 
dosages of dopamine (DA) at core body temperatures at normothermia, at steady state 
hypothermia at 25°C, and during rewarming in the temperature span of 30 - 34°C .  
Paper 3 
To compare differences between immersion cooling and cooling by cardiopulmonary 
bypass (CPB) in cardiovascular function and global delivery and consumption of 
oxygen i) during cooling until deep hypothermic circulatory arrest; ii) during 
rewarming by CPB; and iii) during the 2 h post-hypothermic period following weaning 
from CPB. 
 
Main results and conclusions 
Surface cooling, followed by surface rewarming, resulted in a mild post-hypothermic 
systolic cardiac failure that was well compensated for. Diastolic function was 
unaffected (Paper 1). 
Pharmacokinetics of DA was seriously altered at 25°C and DA did not increase 
cardiac output, but had the adverse effects of increased systemic vascular resistance 
(Paper 2).  
Immersion cooling to hypothermic circulatory arrest, followed by rewarming taking 
place on CPB, resulted in severe and uncompensated cardiovascular failure not 
encountered in CPB-cooled animals (Paper 3).
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4. ABBREVIATIONS 
CPB – cardiopulmonary bypass 
CPBc – animals that were cooled by cardiopulmonary bypass in Paper 3 
CO – cardiac output 
CPP – cerebral perfusion pressure, calculated as MAP - ICP 
CVP – central venous pressure 
DA – dopamine 
DO2 – global delivery of oxygen, calculated as oxygen  content  in  arterial  blood  •  CO 
dP/dT max – maximal acceleration of pressure in the cardiac cycle 
dP/dT min – maximal deceleration of pressure in the cardiac cycle 
Ea – arterial elastance 
Ea/Ees  – arterial-ventricular coupling ratio  
Ees – end systolic elastance, slope of the linear ESPVR for a family of PV-loops during VCO. 
EDP – end diastolic pressure 
EDPVR – end diastolic pressure volume relationship 
EDV – end diastolic volume, in the present paper consisting of LV end diastolic volume and 
the volume of surrounding structures 
ESP – end systolic pressure 
ESV –  end systolic volume, in the present paper consisting of LV end systolic volume and 
the volume of surrounding structures 
ESPVR – end systolic pressure volume relationship 
HCA – hypothermic cardiac arrest 
Hb – hemoglobin  
HR – heart rate 
ICP – intracerebral pressure 
IMMc – animals that were immersion cooled in Paper 3. 
LV – left ventricular 
MAP – mean arterial pressure, calculated as [(2 x diastolic) + systolic] / 3 
PRSW – preload recruitable stroke work , calculated as SW/EDV 
PV – pressure-volume 
Q10 temperature coefficient  – a measure of the rate of change of a biological or chemical 
system as a consequence of changing the temperature by 10 °C. For biological systems, the 
Q10 value is generally between 1 and 3. 
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SR – sarcoplasmatic reticulum 
SV – stroke volume, calculated as CO/HR 
SVR(I) – systemic vascular resistance (index), calculated as SVR = (MAP-CVP) x 80/CO 
SW – stroke work, equals area of the PV-loop 
T½ – half life, the time required for a given plasma concentration of a drug to be reduced to 
50 %. 
Tau – a preload independent measure of isovolumetric relaxation time, based on a 
monoexponential decay model 
TNF-α  – serum tumour necrosis factor alpha  
TnT  – serum troponin-T  
V0 – volume axis intercept of the ESPVR slope determined by PV-loops during VCO 
VCO – vena cava occlusion, abrupt occlusion of the inferior caval vein to obtain PV-loops 
VF – ventricular fibrillation  
VO2 – global consumption of oxygen, calculated as difference of arterial and mixed venous 
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5. INTRODUCTION 
5.1 Classification of hypothermia 
Hypothermia describes a state in which the body's mechanism for temperature 
regulation is overwhelmed in the face of a cold stressor. Hypothermia is classified as 
unintentional or intentional (1). Unintentional primary hypothermia, or simply 
accidental hypothermia as will be used in the present thesis, is due to environmental 
exposure, with no underlying medical condition causing disruption of temperature 
regulation. Unintentional secondary hypothermia is low body temperature resulting 
from a medical illness lowering the temperature set-point or hypothermia secondary to 
major trauma. Iatrogenic hypothermia in the operating theatre can also be classified as 
unintentional secondary hypothermia. Intentional hypothermia encompasses protective 
hypothermia utilized in surgery on the heart and great thoracic vessels, and therapeutic 
hypothermia used to mitigate brain damage after successful resuscitation from cardiac 
arrest. The classification of hypothermia is summarized in Table 1.  










Lowered set-point; major 
trauma and burns





Table 1. Classification of hypothermia 
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In the present thesis the main focus will be on accidental hypothermia. However, as 
discussed  in  the  “Aims  of  the  thesis”  section our methodology and some of our results 
also have relevance for therapeutic and protective hypothermia.  
 
5.2 Ranges of the severity of hypothermia 
Different nomenclatures for the severity of hypothermia exist. Popovic (1974) 
suggested mild above 32°C, moderate 22-32°C, deep 8 – 22 and profound 0 - 8°C (2). 
Wong (1983) made use of mild 32-35°C, moderate 26 - 31°C, and deep 20 - 25°C (3), 
while Moss (1986) applied mild 32-35°C, moderate 28-32°C, and severe below 28°C 
(4), as does the European Resuscitation Council (2010) (5) . 
American Heart Association (AHA), however, makes use of mild hypothermia above 
34°C, moderate 30-34°C, and severe below 30°C (6).  Polderman and Herold (2009) 
apply the same distinction, only substituting "deep" for "severe" for temperatures 
below 30°C, as their topic is therapeutic/protective hypothermia (7).  
For clinical reasons, we think that the AHA definition is the simplest and most 
operational one, appointing 30°C as an important "watershed" temperature marker 
between  “safe”  moderate  (30  - 34°C), and potentially life threatening severe (below 
30°C) hypothermia.  
 
Therefore, in the present thesis the following definition will be used: 
 
Mild hypothermia: 34 - 35°C 
Moderate hypothermia: 30 - 34°C 
Severe (or deep when applied in protective hypothermia) hypothermia: Below 30°C. 
 
It is important to note that the severity of unintentional hypothermia is far more 
dramatic in hypothermia secondary to trauma than in accidental (primary) 
hypothermia. While victims of accidental hypothermia usually have a good prognosis 
if body core temperature is above 30°C, a 100% mortality has been reported in major 
trauma patients presenting with a body core temperature below 32°C (8), and 
hypothermia has been found to be an independent risk factor for mortality in major 
  Ole Magnus Filseth 2012 
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trauma (9). As a consequence, alternative ranges of the severity of hypothermia 
secondary to trauma to those used in accidental hypothermia have been proposed (10).  
 
5.3 Brief historical overview of accidental hypothermia 
One way to justify research projects is to state that the pathological condition in study 
“is  a  major  killer”.  Tempting  as  it  may  be,  there  is  no  evidence  that  accidental  
hypothermia  has  ever  been  one  of  mankind’s  scourges.  Even  in  arctic  societies,  there  
is no documentation that incidence of accidental hypothermia has been higher than in 
more temperate climate zones. The reason for this is obvious: Indigenous peoples in 
circumpolar regions have adapted to the cold, both through sociocultural practises, 
long-term natural selection and individual adaptation. Anyone having read Norwegian 
adventurer  Helge  Ingstad’s  account  of  his  life  among  caribou-eating Canadian Indians 
in  the  1920’ies  will  remember  how  he  managed  to  survive  winters  with  air  
temperatures as low as -60˚C  by  adopting  Indian  clothing and a diet consisting of 
100% caribou without any additives (11). 
However, as this is written, the 8th of February 2012, news agencies report that more 
than 420 people, mostly poor, homeless and from Central and Eastern Europe, have 
died from extreme winter cold in recent days. It is likely that down-scaling of social 
services following globalization and financial crisis will render more people world-
wide in poverty and despair. In combination with extreme weather due to climate 
changes these political conditions will probably lead to increasing numbers of deaths 
from  “urban”  hypothermia  in  the  future. 
 
5.3.1 Accidental hypothermia in war 
When masses of people have been forced into un-physiological and absurd situations 
in the service of war, accidental hypothermia has killed along with steel flying through 
the air, hunger and epidemics. Numerous accounts of war-related accidental 
hypothermic mass death exist. Carthaginian general Hannibal lost 23000 men, 
probably to a large extent due to hypothermia, in a winter crossing through the Alps in 
218-217 B.C. in an attempt to conquer Italy (12). General Armfeldt, subordinate to 
Swedish king Charles 12th and leader of a campaign in Norway in 1718 – 1719 during 
  5. INTRODUCTION 
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the Great Nordic War, ordered his troops to withdraw after the king was killed.  His 
army tried to cross the mountains at Tydal in Norway in January 1719, with the result 
that nearly 5000 soldiers froze to death in severe snow storms (13).  Both Napoleon 
and Hitler were eventually stopped by the cold hostile Russian winter for which their 
troops were not prepared in their attempts to conquer Moscow. 
 
5.3.2 Accidental hypothermia in peace time 
In peace time, mass death from hypothermia has been linked to shipwrecks. Most 
referred  to  is  the  story  of  the  “unsinkable”  steamship  Titanic that hit an iceberg on her 
virgin voyage in 1912. It is believed that cold water and inappropriate clothing killed 
most of the around 1500 people that died in the disaster (14). More recently, the 
potential for hypothermic mass death was present when cruiseship SS Maxim Gorkij 
hit an ice floe near Svalbard in 1989.  Around 1000 passengers, many of whom were 
elderly and wearing only their nightclothes, were evacuated to surrounding ice floes, 
from where they luckily could be saved by Norwegian Coast Guard some hours later 
(15). A similar incident took place in Antartica in 2007 when around 150 people were 
evacuated to lifeboats from the sinking cruiseship MS Explorer. Due to calm weather 
all could be rescued around 5h later by the Norwegian coastal steamer MS Nordnorge 
(16). 
 
5.3.3 Incidence of death from accidental hypothermia 
No national registry for deaths from primary accidental hypothermia (besides general 
death certificates) exists in Norway. In a review article from 1986 it was referred that 
411 deaths from accidental hypothermia was registered from 1945 to 1979, but that 
this number may be misleading, as some of the 200-250 people categorized as dead by 
drowning annually in fact may have been victims of accidental hypothermia (17).  
Based upon own experiences at the University hospital of North Norway (population 
about 500.000) extracorporeal rewarming after accidental hypothermic circulatory 
instability or arrest is undertaken in 3 – 5 patients every year. Of these, snow 
avalanche victims usually die. In addition, in an odd year a person is declared dead 
from hypothermia without being submitted to any hospital. If these numbers reflect the 
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real incidence in the country it could be estimated that the death rate from accidental 
hypothermia in Norway amounts to about 0.5 deaths per 100.000 inhabitants per year. 
This may be in concordance with numbers from other countries in the Northern 
hemisphere, where deaths from accidental hypothermia per 100.000 inhabitants have 
been reported to be 0.13 in France (18), 0.3 in the USA (19) and 2 in Great Britain 
(20).  
Even if deaths from accidental hypothermia may be rare compared with other causes 
of death, hospitals in Norway must be prepared to treat a predictable number of 
hypothermic casualties every year. With increasing activity in subarctic and arctic 
regions in the form of cruise ship tourism, establishment of new circumpolar oil and 
gas fields and increased transcontinental shipping following north pole ice melt-down, 
scenarios of mass hypothermic injury must be incorporated in regional and national 
emergency operation plans.  
In section 5.5.3 prognosis of accidental hypothermia and causes of death will be 
discussed. 
 
5.4 Brief historical overview of hypothermia research 
5.4.1 Research prior to the second world war 
As  mankind’s  history  of  accidental  hypothermia  on  a  large  scale  is  closely  linked  to  
warfare, it is not surprising that great wars combined with the technological 
development during and after the industrial revolution served as catalysts for 
hypothermia  research.  As  a  consequence  of  the  decimation  of  Napoleon’s  armies  by  
the cold during their retreat from Moscow and the futile attempts at rewarming them, 
extensive research on the physiological effects of cooling were performed by French 
physiologists  around  the  1850’ies  (21). During the first world war 12.000 Royal Navy 
sailors, 10.000 merchant seamen and 5.000 German sailors drowned (22). Strangely 
enough, this dreadful statistics did not spur any research efforts to address the cause of 
death and the possible role of hypothermia in the relatively short time span of interwar 
peace (22).  
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5.4.2 The Nazi hypothermia experiments and implications for later hypothermia 
research 
With the onset of the second world war the Germans first saw the need for 
hypothermia research. Of  40.000 men in the German submarine service about 70 % 
lost their lives, many of whom possibly by hypothermia (23). In the air battle with 
Britain, hundreds of pilots from Luftwaffe were shot down over the cold North Sea. 
Some casualties were rescued alive, only to die shortly after rescue. At that time the 
concept of core temperature afterdrop was unknown, as was the cause of the circum-
rescue collapse (23;24). There was no scientific literature describing human
responses to immersion hypothermia, nor information as to the safety and efficacy of 
various rewarming strategies.  
In such a context the Nazi leadership initiated the infamous hypothermia experiments 
in the concentration camp in Dachau in 1942. Part of this context was also, even if 
under-communicated by the victorious nations of the second world war, that use of 
prisoners for experiments was commonplace. In fact, various dangerous and inhumane 
medical experiments on criminal prisoners flourished in the USA during the second 
world war and expanded tremendously after the war, seemingly unaffected by the 
Nurnberg trials that convicted many German researchers to death penalties,  
until the final shut-down  of  prison  experiments  in  the  1970’ies  (25).  
A central question after the second world war has been whether data generated from 
hypothermia experiments on unwilling concentration camp prisoners in Dachau should 
be utilised. While the existence of these data cannot be ignored, it is possible to look 
into this dark chapter of medical research without giving the data generated from the 
experiments any scientific benchmark status, as demonstrated by Pozos (23).  
Some reviewers simply reject data from the Dachau hypothermia experiments on 
grounds that they were poorly designed from a scientific point of view, and conducted 
by criminal outcasts in the German medical society (26). Pozos convincingly 
contradicts this view: The Dachau experiments were not designed as scientific 
research per se, but to find practical solutions to an urgent problem of national 
significance. Besides, modern use of statistics had at that time not permeated medical 
research, and lastly; Dr. Rascher, who was responsible for conducting the experiments,
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was supervised by acknowledged medical authorities (23).   
The data from the hypothermia experiments in Dachau have been extensively used in 
medical literature. From ethical and political reasons, we should not use them, as we 
should abstain from the use of data from abundant inhumane prison experiments in the 
USA and elsewhere in the world in other research areas. However, we should not 
forget that these experiments have taken place. As quoted from a letter from one of 
Pozos’  colleagues:  “When human beings are given differential value then we are all 
vulnerable. The Dachau data is really irrelevant. What is relevant is medicine and 
science’s  placing  differential  value  on  human  life.  If  we  permit  the  continued  
acceptance of the consequences of that evil, then we  are  all  at  risk”  (23). 
 
5.4.4 Hypothermia research after the second world war 
After the end of the second world war it was estimated that 20 – 30.000 men serving in 
the British Navy had died (22). One third was killed in action and two thirds had 
principally drowned due to the cold during the survival phase. The reported deaths 
precipitated an extensive research programme facilitated by the British Navy, and 
resulted in numerous publications and reports (22). In the continuation of this research 
programme researchers like F.S. Golden and M. J. Tipton have specialized within the 
field of accidental immersion in cold water, hypothermia-induced failure of swimming 
as a cause of drowning and the phenomenon of circum-rescue collapse (22;24) 
After the second world war researchers outside the military realm, especially in North 
America, started to conduct cooling and rewarming experiments on intact animals, 
mostly dogs. Aims of studies were to disclose cardiovascular changes and oxygen 
metabolism during cooling and rewarming in addition to factors determining cooling 
rates (27-29). Their focus was not primarily treatment of accidental hypothermia, but 
rather general physiological principles. The practical spin-off would be the utilisation 
of hypothermia as a protective measure in heart surgery (29). During the following 
years similar experiments were performed to examine the effects of hypothermia on 
circulating blood volume (30-32) and the effects of short vs long periods of 
hypothermia on the cardiovascular system (33-35). By the end of the 
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1950’ies  and  the  beginning  of  the  1960’ies  more  sophisticated  methods  were  
developed and used in hypothermia experiments, like application of strain gauge 
arches to assess myocardial contractility in intact animals (36;37), and isolated 
perfused heart preparations for the assessment of intraventriclar pressure-volume (PV) 
loops (38). The effects on the cardiovascular system of cathecholamines like 
epinephrine, nor-epinephrine and DA in hypothermia were also tested in intact animal 
models (39-42), as is further described in section 5.6. 
Examples of experimental hypothermia research areas in the last decades include 
Austrian porcine studies of hypothermia combined with vasopressors during 
cardiopulmonary resuscitation (43), studies on deep hypothermic circulatory arrest 
(HCA) in Oulu, Finland (44), research on trans-capillary fluid shifts during 
hypothermia in Bergen, Norway (45) and cooling-rewarming studies on dogs and rats 
to disclose post-hypothermic cardiovascular failure in Tromsø, Norway (46;47).  
 
5.4.5 Clinical hypothermia research 
When it comes to clinical hypothermia research, numerous studies have been 
performed within the fields of protective and therapeutic hypothermia.  A search for 
“therapeutic  hypothermia”  in  the  Cochrane  data-base per December 2011 revealed 266 
prospective,  randomized  clinical  studies.  When  searching  for  “accidental  
hypothermia”,  only  four  relevant  clinical studies met the Cochrane criteria: Peripheral 
rewarming using a charcoal-fuelled heating device inside a sleeping-bag and inhalation 
rewarming  proved  inefficient  in  volunteers  that  were  cooled  to  35˚C  (48); active 
external rewarming by forced air speeded rewarming in hypothermia victims (49); 
anesthetized volunteers rewarmed faster by active than by passive external rewarming 
(50), and motion sickness increased cooling rate in volunteers (51).  
The majority of clinical reports on accidental hypothermia are in the form of case 
stories. By meta-analysis some general insights may be drawn from these stories. 
Tipton and Golden recently collected 43 reports of victims world-wide who had 
survived prolonged submersion in water (52). No records reported survival if the 
victim had been submersed for more than 30 minutes in water warmer  than  6˚C.  Also,  
only one of 43 surviving casualties was retrieved from saline water (52). 
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There are some retrospective clinical studies analyzing rewarming from accidental 
hypothermia, with a reported mortality ranging from around 30 to 80% (18;53-56). 
In a recent retrospective study of 84 victims of accidental hypothermia from 
Amsterdam, the Netherlands, in their conclusion the authors point to a core problem in 
clinical  research  in  accidental  hypothermia:  “Accidental  hypothermia  is a rare 
diagnosis in an inhomogeneous population, treated with a large variety of rewarming 
techniques.  (…)  Because  individual  teams  gain  little  clinical  experiences,  we  suggest  
multiple centre data collection as a first step towards an evidence-based standard of 
care”  (56). Indeed, some of the authors of the study have collaborated with other 
capacities within the field to launch an international prospective registry, where data of 
individual cases of accidental hypothermia all over the world can be registered in a 
standardized way (57).  
 
5.4.6 Research in the era of molecular biology, genomics and computer simulation: Is 
the intact animal model obsolete? 
In experimental research, ever more sophisticated techniques have been used to isolate 
ever smaller structures. In 1960 Monroe and French isolated the dog heart to extract 
volume-pressure relationships and myocardial oxygen consumption (58). While 
similar set-ups are still commonly used, modern research now also deals with sub-
cellular structures down to the molecular level, for instance to explain excitation-
contraction coupling in cardiomyocytes (59). Such insight is crucial to understand 
basic physiology of heart function. Still, cardiovascular function in intact organisms 
cannot be predicted from knowledge of the function of sub-cellular parts, let alone 
complete organs. As an example, in recent years an integrated view of the interaction 
between vascular tone and cardiac contractility has been pursued through the study of 
the coupling between arterial and cardiac elastance (60;61). The significance of an 
reduced systemic vascular resistence after rewarming from deep hypothermia is not 
necessarily a malfunction of the vasculature, but may be seen as an adaptive measure 
to a post-hypothermic cardiac failure (62).  The combined effect of hypothermia itself 
and the associated low-flow circulation on blood viscosity (63;64), is another factor 
that contributes to the in vivo complex cardiovascular responses to hypothermia that 
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would be nearly impossible to simulate or deduct from the study of single cells or 
organs.  
Another common topic in modern biological and medical research is the study of 
genetics. The mapping of mammalian genomes should in theory be helpful in 
designing experimental models. For instance, in the study of catecholamine effects in 
hypothermia, it might be useful to know that human and porcine  subtypes  of  α-
adrenoceptors are genetically identical and may differ from homologous rodent 
subtypes (65).  Likewise, it could be considered a limitation for a pig model that there 
exists a species-dependent selectivity  of  agonists  to  a  subtype  of  β-adrenoceptors that 
distinguish primates from other mammals (65). However, genomics is not simple 
mathematics: In the majority of organs the adrenoceptors expressed there do not 
correspond to the functional roles they play, also it has been demonstrated that a 
subtype of α-adrenoceptors is non-functional at normothermia, but becomes 
functionally predominant at lower temperatures (65).  To map the genetic expression 
of adrenoceptors in various organs in different species would not predict species-
specific responses to exogenous catecholamines in normothermia nor in hypothermia. 
It seems that we would still have to test and observe using established physiological 
methods.  
 
5.5 Cardiovascular failure and prognosis in accidental hypothermia  
5.5.1 Experimental studies of the effect of hypothermia on cardiac function 
Research results have been somewhat confounding regarding the effect of low body 
temperature per se on myocardial function. From studies on isolated dog and rabbit 
hearts subjected to moderate and severe hypothermia, increased left ventricular (LV) 
contractility and increased cardiac work have been reported (38;66). Core cooling to 
33°C in a pig model mimicking therapeutic hypothermia suggested improved systolic, 
but depressed diastolic function (67); similar results were found in surface cooled dogs 
(68). 
In severe hypothermia, increased LV contractile force was demonstrated in intact dogs 
during surface cooling to 20 to 25°C (37). Likewise, immature swine cooled by 
extracorporeal circuit peaked in LV stroke volume (SV) and work at 29°C (69). On the 
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other hand, intact dogs that were core cooled to 25°C and rewarmed showed reduced 
myocardial contractility during as well as after hypothermia (70). There is 
experimental evidence that long time exposure to severe hypothermia  leads to a 
specific non-ischemic cardiac failure  (35;47;70-72) that is related to intracellular 
accumulation of calcium in cardiomyocytes (73).  
The issue of differences in physiologic effects between species was demonstrated in a 
recent comparative study using cardiac tissue from humans and rabbits that revealed 
reduced inotropy by moderate hypothermia in human as opposed to rabbit (74). The 
findings were related to differences in myocardial tissue sarcoplasmic reticulum Ca2+ 
storage and Ca2+ sensitivity (74). 
 
5.5.2  “Rewarming  shock” 
 The  clinical  term  “rewarming  shock”  has  been  applied  to  describe  the  observation  of  
hypotension and low cardiac output (CO) during rewarming (75). Maclean and 
Emslie-Smith  (1977)  make  use  of  the  synonymous  term  “rewarming  collapse”  as  
resulting from a sudden fall in peripheral resistance unmatched by a compensatory 
increase in CO, frequently encountered in elderly patients in the rewarming phase (76). 
Kuehn  (1983)  alternates  between  “rewarming  collapse”  and  “rewarming  shock”.  The  
proposed mechanism is intravascular hypovolemia during rewarming, as well as 
peripheral vasodilation and possibly release into the circulation of cold, stagnant blood 
(77). There seems to be an unison view that rewarming has to be accompanied by 
infusion of warm fluids to avoid hypovolemia (21;76;78), and that inotropic support 
may  be  added  when  core  body  temperature  exceeds  30˚C    if  CO  is  estimated  to  be  
inappropriately low despite adequate volume substitution (79). It can be questioned 
whether rewarming collapse or rewarming shock describe a frequently encountered 
clinical syndrome, or if the terms merely point to a combination of transient cardiac 
failure, peripheral vasodilatation and reduced circulating blood volume that may or 
may not appear in the rewarming phase. As will be discussed in the following section, 
cardiovascular collapse during rewarming from accidental hypothermia does not seem 
to be a major clinical problem in contemporary medicine.   
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5.5.3 Prognosis of accidental hypothermia and causes of death 
In retrospective studies of accidental hypothermia patients admitted to hospitals, there 
is  a  general  tendency  that  older  studies  (from  the  1970’ies  and  -80’ies)  report  a  high  
mortality, according to Vassal et al between 52 and 80% (18).  In their own institution 
in Paris, Vassal et al reported an overall mortality of 38 % in  65  cases  of  “urban  
hypothermia”  (≤ 32˚C) that were admitted over a long period (1979 – 1998) (18). 
Other European studies report a mortality of around 30% (53;56). Low blood pressure 
on admission (18), slow cooling (53), slow rewarming (18;53), submersion and 
asphyxia (53;56),  old age (18;53;56), indoor exposition and low temperature (56) 
were negative prognostic factors, whereas intoxication by alcohol or narcotics 
favoured survival (18;53).  In the most recent of these studies, van der Ploeg et al 
(2010) report that of 84 hypothermic patients the majority of non-survivors did not die 
during rewarming, but from late multi-organ failure especially involving kidney, liver 
and the coagulation system (56).  
Clearly, prognosis in accidental hypothermia is better if patients present with 
spontaneous circulation and if the admitting institution has a rewarming protocol. Thus 
in Innsbruck, Austria, it was reported that 15 victims of severe accidental hypothermia 
presenting with a spontaneous cardiac rhythm were rewarmed safely and efficiently by 
forced air (54). All patients survived rewarming, however the 6 patients that had  
prehospital cardiac arrest (all were resuscitated to ROSC at admission) did not survive 
long-term, mainly because ischemic brain damage after submersion or avalanche  
accidents. The remaining 9 patients had excellent long-term recovery (54) 
Even if hypothermic patients present with circulatory arrest, or un-stable spontaneous 
circulation at admission, prognosis can be fair if asphyxia did not precede 
hypothermia, and outcome can be excellent even in the most extreme cases (80;81). In 
Bergen, Norway, Farstad et al (2001) collected 11 records of patients belonging to this 
category, of whom 7 survived without neurological deficit (55). No surviving patient 
had a serum K+ value that exceeded 10 mmol/L. 14 of 15 patients with asphyxia 
(drowning or avalanche) preceding hypothermia died, mainly due to irreversible brain 
damage (55). 
 It may seem that in modern day intensive care, the major causes of death from 
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hypothermia are co-morbidity and late multiorgan failure, including irreversible 
ischemic brain damage resulting from asphyxia that preceeded the hypothermic insult. 
 
5.5.4 Circum-rescue collapse 
The  term  “rewarming  collapse”  may  be  confounded  with  the  concept  of  circum-rescue 
collapse, which is applied especially to the rescue of people from water (22;24). 
Circum-rescue collapse implies sudden cardio-vascular derangement and sometimes 
cardiac arrest, not from low body core temperature per se, but from alteration in 
intravascular blood volume distribution during extraction from water and possibly by  
altered blood catecholamine levels at the prospect of rescue (22;24). 
 
5.5.5  “Afterdrop”  as  explanation  of  hypothermic  cardiovascular  failure 
The  term  “afterdrop”  describes  a  fall  in  core  temperature  which  occurs  immediately  
after the surface cooled patient is removed from cold surroundings (17). 
Afterdrop was originally believed to be caused by cold venous blood returning 
centrally from cooler peripheral tissues (21) and to be aggravated by active surface 
rewarming that was believed to cause peripheral vasodilatation and pooling of cold, 
stagnant blood to the heart, thereby inducing cardiac failure and dangerous 
arrhythmias (77). Consequently, core rewarming was considered superior to surface 
rewarming to avoid afterdrop (77). However, afterdrop has been explained by direct 
conduction alone (82), especially since it was also observed in dead pigs (83), and the 
circulatory component in live animals and volunteer humans has been considered 
insignificant (21;84).  
Afterdrop at a rate of 1.4 – 4.0° C/h has been reported in avalanche and immersion 
victims that present with mild or moderate hypothermia at the time of excavation from 
the snow or extraction from water (85;86). Rescue and primary therapy should aim at 
reducing afterdrop and other circum-rescue risk factors. There is however no evidence 
that core rewarming is superior to surface rewarming in avoiding afterdrop, or that 
deliberately slow surface rewarming (for example by keeping limbs during initial 
rewarming
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Figure 1. Afterdrop. Mean changes in temperatures in central venous blood (Tcvb), 
oesophagus (Tes) and rectum (Tre) in 24 anesthetized live pigs cooled to  31˚C,  and  put  directly  
into a tub with hot water. From F.S. Golden (1983)  
 
5.6 Effects of catecholamines and vasoactive drugs in experimental hypothermia  
Different catecholamine and vasoactive drug regimens have been trialled in 
experimental hypothermia.  
In pig models of HCA both epinephrine and vasopressin led to increased coronary 
perfusion pressure during cardiopulmonary resuscitation (87), but epinephrine did not 
result in more successful return to spontaneous circulation (88) and vasopressin did not 
increase short time survival (89).  
The following section deals with models involving a perfusing (spontaneous) 
circulation during hypothermia. 
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5.6.1 Endogenous catecholamine responses during hypothermia 
In awake homoeothermic animals exposure to cold that may lower body temperature is 
stressful and will lead to strong neuroendocrine activation evident from increase in 
plasma concentrations of epinephrine and norepinephrine, and an increase in heart rate 
(HR) and blood pressure (90). Warner et al (1970) subjected dogs anesthetized by 
ether or halothane to profound hypothermia at 15°C by internal cooling (41). 
Apparently the anesthetic level was not deep, as cooling produced an increase in 
plasma levels of epinephrine and nor-epinephrine. 2/3 of the dogs had ventricular 
fibrillation (VF) at a core temperature of 15°C. When the dogs received propranolol or 
compound P-286, a drug thought to prevent release of catecholamines from the adrenal 
gland, no animals had VF at this temperature (41). This suggests a possible 
undesirable effect of sympathetic activation in eliciting VF during cooling.  
There is experimental evidence that the stress reaction of cooling may eliminate the 
positive effects achieved by applying therapeutic hypothermia (91;92). As a 
recognition that it is the combined effect of sedation/anesthesia and hypothermia that 
may favor both the central nervous and the cardiovascular system after ischemic 
damage caused by cardiac arrest, deep sedation is now an integral part of therapeutic 
hypothermia protocols (7).  
 
5.6.2 Effects from administration of epinephrine, nor-epinephrine and dopamine  
Simulation of sympathetic activation during cooling is possible in anesthetized animals 
by administration of exogenous catecholamines. Kondratiev and Tveita (2006) 
demonstrated a significant posthypothermic myocardial depression in rats treated with 
epinephrine during cooling compared to temperature-matched controls (93). 
Epinephrine administered during rewarming also had negative effects: Epinephrine in 
a dose that induces vasodilatation and elevated CO in normothermia resulted in 
vasoconstriction without elevation in CO when administered during rewarming from 
24°C (94). The posthypothermic CO and left ventricular SV was reduced by 30 % in 
rats treated with epinephrine during rewarming compared to temperature matched 
controls (94).  
The findings of Kondratiev et al parallel those of Rubinstein (1961) that a defined
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dosage of epinephrine given to dogs caused vasodilatation in normothermia, but 
increased total systemic vascular resistance (SVR) at 25° C (95).  
The arrhythmogenic effect of exogenous epinephrine during cooling was demonstrated 
by Angelakos and Daniels (1969), who surface cooled anesthetized dogs until a 
terminal temperature when VF or asystole occurred (42). Epinephrine infusion 
increased the incidence of VF from 60 to 100% and increased the terminal temperature 
from 19,3 to 21,9°C.  
While some unfavourable effects of epinephrine in experimental hypothermia have 
been demonstrated, most studies so far involving DA in the same setting could give 
the impression that DA is a more appropriate drug. In the study by Angelakos and 
Daniels described above DA had a seemingly protective effect against VF, since 
infusions of DA (and nor-epinephrine) reduced the incidence of VF from 60 to 20 % 
and the terminal temperature from 19,3 to 12,5°C (42).  
Nicodemus et al (1981) demonstrated that  a  DA  infusion  at  12  μg/kg/min  during  
internal rewarming of anesthetized dogs from 25°C reversed cold-induced 
cardiovascular depression without causing ventricular arrhythmias (96).  Oung et al 
(1992) reported that optimal dosage for DA to improve CO in pigs at different core 
temperatures  (30 - 38,5°C) was 10 – 20  μg/kg/min  and  that  no  arrhythmias  occurred  
except  for  sinus  tachycardia  at  dosages  up  to  30  μg/kg/min  (97). In a study of lung-
transplanted pigs that were immersion cooled to 32°C DA in dosages of 5 and 12 
μg/kg/min  decreased  mean  arterial  pressure  (MAP),  but  increased  cardiac  index  (CI)  
and had no effect on pulmonary vascular resistance (98). A negative side effect of DA 
during hypothermia was reported as a DA-dependent increase in left ventricular end-
diastolic pressure (LVEDP) in anesthetized sheep core cooled to 29°C (99). 
 
5.7 Clinical use of catecholamines in hypothermia 
Due to lack of human studies, the recommendations for the clinical use of 
catecholamines in accidental hypothermia are based on animal experiments or clinical 
experience and corollary the opinions have been somewhat differing. Wong (1983) 
postulated that positive inotropic cardiac effects of catecholamines are enhanced 
during mild to moderate hypothermia and depressed at deep hypothermia (3). Danzl 
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(1994) stated in general terms that target organs and sytems become progressiveliy less 
responsive to medications as the core temperature falls (100), similar to the view of 
Lloyd (1996), who claimed that the hypothermic heart is unresponsive to pacing and 
cardioactive drugs (82). 
In general, both European and North American guidelines advice against inotropic or 
anti-arrhythmic drugs at core temperatures below 30°C, the reason being that these 
drugs are considered ineffective in deep hypothermia and may accumulate to toxic 
quantities (5;6). According to these guidelines drugs may be used at body core 
temperatures above 30°C but with increased interval between doses. Mechem and 
Danzl (2008) advocate the use of a low-dose infusion (2 to 5 microg/min) of DA in 
victims of deep or moderate hypothermia when the circulation is estimated to be 
unsustainable in spite of adequate fluid resuscitation (79), a recommendeation that is 
based on experimental studies on pigs and sheep referred to above (97;99).  
Even if written guidelines for the use of inotropic medication at reduced core 
temperatures are scarce and based on a limited number of preclinical studies it has 
been reported that a majority of hypothermic patients receive inotropic drug therapy 
when treated with moderate therapeutic hypothermia after resuscitation 
from cardiac arrest (101;102), or during rewarming from accidental hypothermia 
(18;54). In contrast, in patients hospitalized for acute heart failure without 
hypothermia, a subgroup of about only 10% received inotropic drugs (103). 
 
5.8 Pharmacology of hypothermia 
The knowledge of the effect of hypothermia on the pharmacology of various drugs 
seems relatively sparse (107). Tortorici et al (2007) reviewed twenty-one studies on 
hypothermia-mediated alterations on the cytochrome P450 enzyme system (108). 
Among the drugs studied were opiates, benzodiazepines, barbiturates and 
nevromuscular blockers. They found that mild to moderate hypothermia in humans 
decreased the systemic clearance of the drugs between ~7 % and 22 % per degree 
Celsius below 37°C and that hypothermia decreases the potency and efficacy of certain 
drugs. As catecholamines are metabolised by uptake in nerve endings and by the 
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enzymes monoamine oxidase (MAO) and catechol-O-methyl transferase (COMT) they 
were not the aim of study. In their review article, Pedersen et al (2007) likewise do not 
deal with catecholamines other than citing an article by Cotton et al from 1957 that 
demonstrated attenuated effect of nor-epinephrine on contractility and arterial blood 
pressure during hypothermia in an experimental setting (109). 
 
5.9 Clinical rewarming from accidental hypothermia 
Various techniques in rewarming victims of accidental hypothermia have been 
described: Passive, or spontaneous rewarming, relying on endogenous heat producton 
and facilitated by insulation (for example carpets) and warm surroundings, and active 
rewarming where heat is conveyed to the victim. Active rewarming takes place by 
surface rewarming, or by core (internal) rewarming. Surface rewarming can take place 
by immersion in warm water, by packing in warm blankets, by charcoal-driven devices 
inside sleeping bags and by forced warm air (19, 48, 49, 82). Several forms of active 
core rewarming have been proposed for hypothermic victims: Airway warming, 
irrigation of body cavities ( mediastinum, pleura, peritoneum), intragastric, 
intraoesophageal and intracolonic devices, intravenous fluids, and  cardiopulmonary 
bypass (19,82). However, there is support in the literature that intra-hospital 
management of hypothermic victims can be substantially simplified: Victims of 
accidental hypothermia presenting with what is judged as sustainable, spontaneous 
circulation can be successfully surface rewarmed by forced air irrespective of the core 
body temperature on admission (54). If circulation is judged unsustainable (asystole, 
ventricular fibrilliation or other serious arrhythmias; severley reduced cardiac output) 
rewarming by cardiopulmonary bypass (CPB) is the preferred method, both in adults 
and children (55, 123, 124).   
While the controlled cooling by CPB until deep HCA at 15 – 18°C to perform 
complex aortic surgery followed by rewarming results in an overall hospital mortality 
of only around 5% (111, 112), hospital mortality of victims of accidental hypothermia 
that are rewarmed by CPB has been reported to be as high as 70 –  87% (55, 110).  
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6. AIMS OF THE THESIS 
The studies that the present thesis is based upon were initiated in 2003, highly inspired 
by the successful and sensational resuscitation of a young woman that was admitted to 
our institution with a core temperature of  13.7˚C  (80).  
In developing an intact pig model to study the whole time-course of cooling to severe 
hypothermia, followed by steady state hypothermia, rewarming and post-hypothermic 
expiration, we have revisited hypothermia experiments initiated by the pioneers 60 
years ago.  
The reason for undertaking Paper 1 was the somewhat confounding results from earlier 
experimental hypothermia research regarding low body temperature per se on 
myocardial and vascular function (62). Among questions to be raised and discussed 
are:  
- Is hypothermia-induced heart failure after rewarming from deep hypothermia 
characterized by both systolic and diastolic failure, as seen in myocardial 
stunning? 
- Do post-hypothermic changes in SVR  express adaptive measures or  
compensatory incapacitation? 
Paramount in the effort to answer these questions was the use of an indwelling 
conductance catheter in the left cardiac ventricle to extract pressure-volume and 
contractility data. 
Background for the study in Paper 2 was the discrepancy between the limited 
knowledge about pharmacologic effects and pharmacokinetic properties of 
catecholamines in hypothermia, and the widespread use of catecholamine drug therapy 
in patients undergoing moderate therapeutic hypothermia (101;102) or rewarming 
from accidental hypothermia (18;54). 
As in Paper 1, Paper 2 makes use of the conductance catheter as a crucial tool to study 
the interaction between the heart, the vasculature and the circulating blood volume 
under the influence of DA at various core body temperatures.  
In Paper 3, we would try to address the clinical experience that extracorporeal 
rewarming followed by intensive care of victims of severe accidental hypothermia 
seems much more complicated than the routine rewarming by CPB of patients 
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undergoing deep protective HCA for surgery on the proximal aorta (55;110-112). 
Would there be any difference in outcome if the only difference between the 
experimental groups was the cooling method; surface cooling vs. cooling by 
cardiopulmonary bypass (CPB)?   
Accidental hypothermia has remained the main aim in the present thesis. However, as 
will be discussed later, our methodology and some of our results also have relevance 
to therapeutic and protective hypothermia.  
Specifically, the aims of the papers are as follows: 
 
Paper 1. 
The aim of paper 1 was to develop a minimally invasive, closed chest pig model to 
describe in detail the hemodynamic function with emphasis on left ventricular 
contractility during surface cooling, steady state severe hypothermia at 25°C, surface 
rewarming and in the 2 h post-hypothermic period.   
 
Paper 2 
The aim of paper 2 was to use the model established for paper 1 to 1) carry out a 
detailed analysis of the cardiovascular response to incrementing dosages of DA at core 
body temperatures at normothermia, at steady state hypothermia at 25°C, and during 
rewarming in the temperature span of 30 - 34°C; and 2) investigate the 
pharmacokinetic properties of DA in normothermia and hypothermia. Also, we 
investigated 3) whether substantial doses of DA given during hypothermia would blunt 
the post-hypothermic effects of DA, and 4) the effect of DA on the rate of rewarming. 
 
Paper 3 
The aim of paper 3 was to compare differences between immersion cooling and 
cooling by CPB on 1) cardiovascular function and global delivery and consumption of 
oxygen and 2) brain perfusion pressure and brain metabolism in an intact pig model in 
different phases: i) during cooling until severe/deep HCA; ii) during rewarming by 
CPB; and iii) during the 2 h post-hypothermic period following weaning from CPB. 
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7. METHODOLOGICAL CONSIDERATIONS 
In the description of material and methods the names and addresses of producers of 
various equipments are largely omitted to enhance readability. In the original papers 
that are attached this information is included.  
Descriptions of standard hemodynamic recordings and calculations, as well as 
biochemical analyses are made rather short and straight-forward. When it comes to 




Previous experimental hypothermia studies of surface cooling/rewarming in animals 
with maintained circulation have been performed using rodents (34;47) and dogs 
(33;113). However, cardiovascular responses to hypothermia in these species may 
differ from humans since rodents increase their SV during severe hypothermia (47;94), 
whereas in dogs, whose SV remain unchanged at this temperature zone,  an elevated 
SVR is maintained after rewarming even from prolonged surface hypothermia 
(33;113), contrary to what has been reported from the clinical rewarming in accidental 
hypothermia (76, 77).  
The apparently closer morphologic and physiologic relationship between humans and 
pigs suggests that a porcine model is more suitable for translational research (114). 
There were also other reasons for selecting the pig as model animal: In Papers 1 and 2 
we utilized an indwelling conductance catheter in the left ventricle, a technique 
established by other researchers in pig models at our lab (115;116).  In Paper 3, we 
used CPB in the control group during cooling, and on animals in both control - and 
study groups during rewarming. In this respect, we could lean on other researchers at 
our lab who have applied normothermic CPB in porcine models for many years. We 
also visited Finnish researchers led by T. Juvonen that have an extensive experience in 
chronic porcine models of deep HCA lasting 75 min before rewarming and recovery 
(44). 
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The animals used were 2 – 3 months old castrated male pigs weighing 24 - 37 kg. The 
breeds were either a native Norwegian stock (norsk landsvin) (Papers 1 and 2), or a 
hybrid crossing of native Norwegian and British Yorkshire breeds (Paper 3). 
 
7.2 Ethics 
Experimental protocols were approved by the local steering committee of the 
Norwegian Animal Experiments Authority. The animals received humane care in 
accordance with The Norwegian Animal Welfare Act. After arrival at the laboratory 
animal unit they were placed in pens for 2 – 5 days, where they were fed twice daily 
and had free access to water at all times.  
During experiments, the animals were deeply anesthetized. The anesthesia protocol 
was similar in all series. After termination of experiments animals were killed with 20 
mmol potassium chloride given as an i.v. bolus.  No neuromuscular blockers were 
used at any time. 
Fig. 2 (analyses from animals in Papers 1 and 2) demonstrates that no increase in the 
stress hormone epinephrine was detected throughout experiments. For comparison, I 
have included Fig 3 showing the stress response of surface cooling without use of 
anesthetics in an animal study from the USA (90). 
 
                                         
Figure 2. Plasma concentrations of epinephrine during cooling and rewarming in 
deeply sedated pigs in the present studies. 
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Figure 3. Plasma concentrations of epinephrine during cooling and 
rewarming in awake baboons. From Chernow et al (1983). 
 
7.3 Study design 
All studies were performed as acute, prospective, open, placebo-controlled 
experimental studies in the animal research laboratory affiliated to the University of 
Tromsø, Norway. In Papers 2 and 3, randomisation between study- and control groups 
was also performed. 
In Paper 1, 8 animals were surface  cooled  and  kept  at  25˚C  core  temperature  for  1  h  
before  rewarming.  Comparisons  were  made  “within  group”,  or  “between  groups”  
when compared with time-matched normothermic controls, n = 4.  
In Paper 2, the 8 animals that comprised the study group in Paper 1 were used as 
controls for the 8 animals that received DA in incrementing dosages during deep 
hypothermia  (25˚C)  and  during  rewarming  at  moderate  hypothermia  (30  – 34  ˚C).  
Randomization of animals between groups was performed simply by blindly assigning 
every other pig to either group before entering the animal lab.  
In Paper 3, 8 animals in the study group were immersion cooled to cardiac arrest, 
while control animals were cooled by CPB to a pre-determined  temperature  of  18˚C  
measured in the oesophagus. After 75 min of deep HCA, animals in both groups were 
rewarmed by CPB, and observed for 2 h after weaning from CPB. Randomization was 
performed as in Paper 2. 
Fig. 3 shows the protocol flow chart for animals in Papers 1 and 2. In Paper 1, group B 
in the flow chart is the study group, whereas the 4 control animals are not included. 
In Paper 2, group A in the flow chart is the study group and group B serve as controls. 
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Figure 3. Flow chart for Papers 1 and 2.  
 
    Figure 4. Flow chart for Paper 3.
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For clarity, I also include time-course figures for each study, showing the actual 
measured time-dependent temperatures. 
       
    
 Figure 5. Time-dependent temperatures in Paper 1 (error bars not included). 
 
 
                  
    Figure 6. Time-dependent temperatures in Paper 2. 
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Figure 7. Time-dependent temperatures in Paper 3. A, Temperatures in oesophagus vs 
time; B, Temperatures in urinary bladder vs time; HCA, hypothermic circulatory arrest. ‡ 
Significant difference in temperature between immersion cooled and CPB-cooled animals (P 
≤  0.05).  Arrows  denote  start  of  cooling  in  respective  groups. 
 
7.4 Anesthesia and respirator protocol 
Animals in all series received the same anesthetic protocol. After an overnight fast, 
anesthesia was induced in the pen by an intramuscular bolus of ketamine 
hydrochloride 20 mg/kg, midazolam 25 mg and atropine 1.0 mg. After transfer to the 
animal research operating theatre, a catheter was inserted into an ear vein and a bolus
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injection of fentanyl 10 μg/kg and pentobarbital-sodium 10 mg/kg was given. After 
tracheostomy a continuous right external jugular vein infusion of fentanyl 20 μg/ 
kg/h, pentobarbital-sodium  4  mg/kg/h  and  midazolam  0.3  mg/kg/h  along  with  Ringer’s  
acetate 9 ml/kg/h was started and maintained throughout the experiment, except for the 
one-hour period at 25°C core temperature. After termination of experiments the 
animals were killed with 20 mmol potassium chloride given as an intravenous bolus. 
No neuromuscular blockers were used at any time.  
Animals were maintained on intermittent positive pressure ventilation and a positive 
end expiratory pressure (PEEP) of 4 cm H2O was applied throughout the experiments. 
FiO2 was adjusted to maintain PaO2 >10 kPa, and alveolar ventilation adjusted to keep 
PaCO2 of  4.5  to  6  kPa  uncorrected  for  temperature  (α-stat management). 
 
7.5 Recording and calculation of hemodynamic variables 
Recording and calculation of standard hemodynamic variables were done in the same 
manner in all papers and are only briefly summarized. 
ECG from standard leads, heart rate (HR), central venous pressure (CVP), MAP, and 
pulmonary artery pressure (PAP) were continuously displayed on a data monitor and 
intermittently recorded using a computer program designed at our department. At pre-
determined temperatures CO was measured in triplets, by injecting 5 ml precooled 
saline in a thermodilution catheter positioned in the pulmonary artery. SV and SVR 
were calculated as: SV = CO/HR; SVR = (MAP - CVP) · 80/ CO. To index SVR body 
surface area (BSA) was calculated according to the formula: BSA in m2 = (734 · body 
weight · 0.656): 10000 (117). Global delivery and consumption of oxygen (DO2 and 
VO2) were calculated as oxygen content in arterial blood · CO, and the difference of 
arterial and mixed venous oxygen content · CO, respectively. 
 
7.6 Biochemical analyses 
7.6.1 Catecholamines (papers 1 and 2) 
Blood with heparin (4 IU/ml), reduced glutathione (4.5 mM) and EDTA (5 mM) was 
kept on ice/water for maximally 30 minutes before plasma was obtained by 
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centrifugation (1000 × g) for 20 minutes at 4°C. Samples were stored at -80°C 
awaiting analysis. Plasma samples (1 to 2 ml) were spiked with known 
concentrations of the internal standard (DHBA = dihydroxy- benzylamine) and added 
1 ml 2 M Tris-EDTA buffer (pH 8.7). The catecholamines were adsorbed onto 
alumina (10 mg). After aspiration of plasma/buffer, the alumina was washed three 
times with bi-distilled water (1 ml). The catecholamines were eluted from the alumina 
with a mixture (100 μl) comprising acetic acid (175 mM), sodium bisulfide (9 mM) 
and EDTA (0.7mM). After whirling and centrifugation, the aquous phase was 
aspirated and transferred to the autoinjector. DA, norepinephrine and epinephrine were 
separated by HPLC and their concentrations determined with an electrochemical 
detector. The analyses were performed at ambient temperature with a flow of 1.2 
ml/ml. 
 
7.6.2 Other analyses 
Hemoglobin (Hb) measurements, and arterial and mixed venous blood gases 
uncorrected for temperature were analysed on a blood gas analyser. Blood samples for 
serum analysis were put on ice, quickly centrifuged and the serum was then quickly 
frozen and kept at -80°C awaiting analysis. Tumor necrosis factor alpha (TNF-a) was 
analysed by the quantitative sandwich enzyme immunoassay technique. Troponin T 
(TnT), ASAT, ALAT and albumin were analysed by the sandwich method of 
electrochemiluminescence, UV-test with pyridoxal phosphate activation, and a 
colorimetric end point method.  
 
7.7 Postmortem wet/dry organ weight ratios (Paper 3) 
After the animal had died or was killed, autopsy was performed and representative 
samples of various organs as specified in Fig. 7 were excised, weighed and stored 
overnight in an incubator at 60°C, before weighing was repeated followed by 
calculation of wet/dry ratios. 
7.8 Conductance catheter methods (Papers 1 and 2) 
Since there are changes in circulating blood volume during cooling and rewarming 
(31;118;119), variations in preload conditions were likely to occur in our experiments. 
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Because assessing the heart contractility during hypothermia and during catecholamine 
infusions was one of the main goals in Papers 1 and 2, priority would be given to 
obtain preload independent measures of contractility. 
In an attempt to isolate the intrinsic ability of the myocard to generate force and 
shortening independent of preload, afterload or heart rate, H. Suga developed the 
concept of end systolic elastance (Ees), calculated from PV loops during occlusion of 
the inferior caval vein (120).  
The  assessment  of  “true  contractility”  of  the  hypothermic  heart  was  our  main  motif  for  
inserting a conductance catheter (CD Leycom, Zoetermeer, The Netherlands) via the 
left carotid artery into the left ventricle in animals in Papers 1 and 2.  
 
                                                              
                          Figure 8. Conductance catheter placement in left ventricle. 
 
The part of the conductance catheter that is placed inside the left ventricle (LV) is 
equipped with a pressure sensor and with pairs of electrodes; one which create an 
electrical field wheras the other measure the ensuing conductance which is dependent 
on the amount of blood surrounding the pair of electrodes. Each pair of measuring 
electrodes thus measures a slice of blood volume, as is illustrated in Fig. 8. The sum of 
these blood volumes comprise the volume at any given instant within the left ventricle. 
Because the electrodes measure relatively few volume slices, the obtained sum of 
segmental conductances has to be corrected by an independent estimate of SV (121). 
In our experiments, CO measured by the thermodilution method divided by HR 
determined the SV against which the sum of segmental conductances was corrected. 
By correcting conductance-derived SV against this independent method, we also 
eliminated the effect of blood resistivity on measured conductance.                                                                                                           
Several indices of LV contractility and relaxation throughout the heart cycle (Fig. 9) 
 7. METHODOLOGICAL CONSIDERATIONS 
 41 
may be derived from the PV loop. We made use of dP/dtmax, dP/dtmin, the time constant 
of isovolumetric relaxation (Tau) based on a monoexponential decay 
model, end diastolic PV relationship (EDPVR), end systolic elastance (Ees, or end 
systolic PV relationship (ESPVR)) and preload recruitable stroke work (PRSW). 
Furthermore, we also included the interaction between LV function and the arterial 
system, by calculating arterial elastance (Ea) as end systolic pressure/SV and finally 
calculating arterial-ventricular coupling ratio as Ea/Ees. 
The conductance derived LV end diastolic and end systolic volumes (EDV and ESV) 
resulted from intraventricular conductance and the conductance of surrounding 
structures (above all the myocardium), called parallel conductance. Parallel 
conductance determination by use of repetitive hypertonic (30%) saline infusions at 
each temperature was not performed, as this would have lead to considerable NaCl 
accumulation throughout the experiment. Consequently, EDV and ESV in our studies 
did not represent real LV volumes, and no measure of LV ejection fraction could be 
calculated. However, recording of relative LV volume changes during cooling and 
rewarming could be performed. PRSW is the relationship between stroke work (see 
Fig.9) and EDV, and is thus affected by parallel conductance, however it is not the 
absolute PRSW values that are of interest, but the changes in PRSW due to various 
interventions. The same reasoning applies to the calculation of EDPVR. The use of PV 
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Figure 9. Pressure-volume loop of the heart. The area within the loop equals the stroke 
work (SW). a, diastole; b, iso-volumetric contraction; c, systole; d, iso-volumetric relaxation; 
SV, stroke volume; ESV, end systolic volume; EDV, end diastolic volume; LVP, left 
ventricular pressure; ESPVR; end systolic pressure-volume relationship; EDPVR, end 
diastolic pressure-volume relationship; Ees, end systolic elastance, dP/dtmax, maximal 
acceleration of pressure in the cardiac cycle; dP/dtmin, maximal deceleration of pressure in 
the cardiac cycle. 
 
7.8.1 Determination of end systolic elastance, preload recruitable stroke work and end 
diastolic pressure/volume relationship 
The conductance catheter placement was guided by LV pressure signals being 
displayed on a monitor and by advancing the catheter to obtain the maximum number 
of electrode segments displaying ventricular volumes without causing ventricular 
arrhythmias. Segments lying outside the ventricle were excluded before each 
recording. 
LV contractility indices Ees, EDPVR and PRSW were calculated based on PV 
recordings during abrupt inferior vena cava occlusions by a balloon catheter advanced 
via the femoral vein to the inferior caval vein.  
Fig. 10 shows the principle for determination of Ees and EDPVR . The slope of the 
line resulting from the end-systolic points during preload reduction (red dots) denotes 
Ees, while the slope of the line drawn between corresponding end-diastolic points 
(blue dots) denotes EDPVR. V0 was defined by the intercept of the Ees slope of the 
volume axis (not shown in Fig. 10).
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Figure 10. Pressure-volume loops recorded during occlusion of vena cava inferior 
 
Fig.11 shows how PRSW is calculated by plotting SW against EDV during abrupt 
vena cava occlusions. 
 
            
           Figure 11. Determination of preload recruitable stroke work (PRSW).  
 
 
At core temperatures below 30°C inferior caval occlusions did not induce changes in 
PV loops that could be applied to calculate PRSW, EDPVR or Ees, probably 
because the heart obtained most of its filling from the superior caval vein in this low-
flow state.  
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7.9 Brain microdialysis and intracerebral monitoring (Paper 3) 
7.9.1 Microdialysis 
Traditionally, researchers have gained information about cellular and tissue 
metabolism indirectly via blood samples. During the last two decades, however, 
microdialysis techniques have been refined to retrieve metabolites from tissue 
interstitium, making assessment of dynamic changes in isolated organ metabolism 
more precise (122).  
This was why we wanted to apply this method to monitor brain metabolism in Paper 3.  
An area of approximately 2 x 5 cm of the skull over the right hemisphere was exposed 
by excision of the scalp. A microdialysis catheter was placed to a depth of 10 mm 
below the dura mater through a cranial hole 1 cm right to the sagital suture and 2 cm 
ventral to the coronal suture. The catheter was connected to a 1,0 ml syringe placed 
into a microinfusion pump and perfused with Ringer solution at a rate of 2,0 µl/min. 
Sampling time was 30 minutes at five times during the experiment: At baseline, at 
30°C and 20°C during cooling, at 30°C during rewarming and 2 hrs after end of 
rewarming. The microvials containing the dialysate fluid were immediately frozen at -
70°C and concentrations of cerebral tissue glucose, lactate, pyruvate, glutamate and 
glycerol were measured later with a  microdialysis analyzer (CMA 600, 
CMA/Microdialysis). 
Fig. 12 shows how exchange of solutes occurs in both directions across a 
semipermeable membrane of the probe, depending on the orientation of the solute 
concentration gradients (122).  
 
7.9.2 Other intracerebral monitoring  
A pressure-monitoring catheter for recording of intracerebral pressure (ICP) and a 
temperature probe for monitoring intracerebral temperature was placed in the brain 
parenchyma just below the dura mater through another cranial hole 1 cm to the right of 
the sagital suture and 1 cm dorsal to the coronal suture. ICP was displayed 
continuously on a monitor and recorded manually at different time intervals. CCP was 
calculated as MAP – ICP.  A catheter was placed retrograde through the left internal 
jugular vein to sample blood for determination of jugular venous oxygen saturation.
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Figure 12.  Principles of microdialysis. A microdialysis probe of concentric design is shown. 
The magnified membrane region illustrates net diffusion of a compound (analyte) of interest 
(open circles) into the probe, as well as the net diffusion of the calibrator (closed circles), 
which has been added to the perfusate, from the probe to the extracellular space (122).
                         
                                
Figure 13. Cerebral monitoring. Left, microdialysis vial and probe; right, pressure 
transducer and thermistor.  
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7.10 Cooling and rewarming 
7.10.1 Temperature monitoring 
In Papers 1 and 2 the core temperature was recorded from a thermistor in the 
thermodilution catheter positioned in the pulmonary artery.  
In Paper 3, due to the brain monitoring and the over-all more complex body 
temperature changes associated with CPB, body temperature was monitored 
continuously at four places: Brain, oesophagus, urinary bladder (via the urine catheter) 
and pulmonary artery (via the thermodilution catheter). During CPB, temperatures 
were also monitored in the venous and arterial lines and displayed on the centrifugal 
pump machine. Oesophageal temperature was used as reference temperature, 
determining sampling points throughout experiments and end point of cooling, 
whereas the point of weaning from CPB during rewarming was determined by urinary 
bladder temperature. Brain temperature was used to withdraw anesthetics at 
temperatures below 25°C. 
 
7.10.2 Immersion cooling and rewarming (Papers 1 and 2). 
After instrumentation all surgical wounds were sutured in two layers and the animals 
were laid in a right lateral recumbent position on the operating table. By use of a 
centrifugal pump and a heat-exchanger, cold water (5°C) circulated the hollow 
operating table and a tarpaulin tub surrounding the animal. The upper left side of the 
animal was covered with ice slush and irrigated by cold water leaving two thirds 
of the dependent animal submerged. The head was placed on a cushion and not 
immersed or covered with ice slush (Fig. 14). At 26°C core temperature cold water 
circulation was discontinued, the tub drained for water and ice slush, and core 
temperature subsequently dropped to approximately 25°C in all animals. To prevent 
core temperature from a further drop, small amounts of warm water was added to the 
tub. Rewarming was achieved by circulating the operating table and the tub, and by 
irrigating the upper left side of the animal, with hot water (40 to 42°C, measured in the 
afferent water hose) till rewarming (38°C) was accomplished. 
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                                                  Figure 14. Immersion cooling. 
 
7.10.3 Immersion cooling in Paper 3 
Animals in the study group in paper 3 were immersion cooled just like the animals in 
papers 1 and 2, with the exception that the cooling end point was not a predetermined 
temperature, but simply HCA. From pilot experiments, we expected asystole to occur 
at 18 – 22°C. As oesophageal temperature fell below 24°C and
serious bradycardia (< 20 beats/min) developed, cold water circulation was 
discontinued and the tub was drained for water and ice slush. Subsequently 
oesophageal temperature invariably dropped further, and with the onset of asystole 
preparations for sternotomy and attachment to CPB started.  
 
7.10.4 Cardiopulmonary bypass (Paper 3) 
Animals in the control group were cooled by CPB to a predetermined core temperature 
at 18°C. Animals in both groups were rewarmed by CPB until 36°C in the urinary 
bladder.  
Extracorporeal rewarming is considered the best rewarming technique in victims of 
accidental hypothermia that present with asystole or an unsustainable circulation (6). 
In adult patients, femoro-femoral cannulation is the methode of choice because its 
simplicity and the possibility to maintain external cardiac compression until bypass is 
establsihed (123). However, in small children and infants, some clinicians advocate 
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median sternotomy and central cannulation to improve venous return (124). In our 
pilot experiments we found the femoral vessels in the juvenile pigs too gracile to insert 
large enough cannulas to ensure sufficient CPB flow. Therefore we chose central 
cannulation, allowing us to use a single stage 24 F venous cannula in the right atrium 
and a 16 F arterial cannula in the ascending aorta.  
Other researchers have studied extravasation during experimental hypothermic CPB, 
utilizing a traditional CPB set-up with a reservoir of stagnant blood that serves as a 
volume buffer during the bypass (125). The advantage of the reservoir is that volume 
substitution to the circuit can be titrated so that the fluid level in the reservoir is kept 
constant (125). The disadvantages are that stagnant blood requires more aggressive 
anti-coagulation, with the potential of increased bleeding, especially during deep 
hypothermic CPB, and that circuit priming volume increases, with the result that 
hemoglobin concentration drops to an un-acceptable low level (< 5 g/dl) in a small 
animal.  Therefore, we chose a heparin-coated circuit without reservoir and with a 
highly efficient, low-volume oxygenator (Jostra Quadrox, Maquet Cardiopulmonary, 
Hirrlingen, Germany). Priming volume was thus reduced to about 500 ml and anti-
coagulation end point was an activated clotting time (ACT) of around 200 sec.   
As appears in Fig. 15, fluid was added to the circuit if a negative access pressure 
occurred in the venous cannula when pump rotational speed was increased to reach 
CPB end points of MAP above 50 mm Hg and oxygen saturation in mixed venous 
blood above 60 %.  
 
7.10.5 Cooling and rewarming by cardiopulmonary bypass 
Cooling and rewarming while on CPB was performed using the heat-exchanger 
attached to the oxygenator to achieve a temperature gradient of maximum 5°C 
between drain blood in the venous line and inflowing blood in the arterial line. 
However, during rewarming maximum temperature in the inflowing arterial line was 
set at 39 °C and the temperature gradient between the urinary bladder and blood in the 
arterial line was not allowed to exceed 10°C. 
When animals in the CPBc group had been cooled until 18°C in oesophagus, CPB was 
withdrawn, the aorta was cross-clamped distal to the aortic cannula and 400 ml of cold 
 7.METHODOLOGICAL CONSIDERATIONS 
 49 
(4°C) crystalloid hyperkalemic cardioplegic solution (126)  was added via the aortic 
cannula to produce cardiac arrest.  
During rewarming internal electroconversion of VF would be initiated at an 
oesophagal temperature of 25°C. If three attempts at electroconversion were 
unsuccessfull up to an oesophagal temperature of 28°C, a bolus of 150 mg amiodarone 
was administered in the arterial cannula before additional electroconversions. 
Weaning from CPB was performed when temperature measured in the urinary bladder 
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7.11 Dopamine as study drug: Characteristics and effects  
The reasons for choosing DA as catecholamine study drug in this thesis are the 
widespread use of DA in perioperative and intensive care, the explicit recommendation 
for its use in accidental hypothermia guidelines (79) and the above mentioned possible 
positive effects after testing DA during experimental hypothermic conditions.  
DA is an endogenous biogenic amine synthesized from the amino acid tyrosine in 
nerve axon terminals in the central nervous system, where it acts as a neurotransmitter. 
As a member of the catecholamine family, DA is a precursor to nor-epinephrine and 
epinephrine (104). 
In man, DA activates DA, and β-adrenergic and α-adrenergic receptors at all dosages, 
but the relative importance of the effect of receptor activation is dose dependent. Thus 
in man, low-dose DA (2–4 μg/kg/min) improves renal blood flow and increases 
diuretic output through activation of DA receptors (105). At moderate-doses DA (4–10 
μg/kg/min) in humans, effects from β-adrenergic cardiac receptor stimulation 
predominate, and CI increases by increasing stroke index (SI) (106).  High dose DA 
(above 10 μg/kg/min) in man engages α-adrenergic receptors relatively more than at 
lower doses, leading to increased SVR (105). 
Despite the vast amount on research of the pharmacology on DA, all but few works 
address the effects in normothermia, and studies of DA pharmacokinetics in 
hypothermia are virtually non-existent.  
 
7.12 Statistics 
Statistical analyses were performed using SigmaPlot statistical software version 9–11 
(Systat Software, Richmond, CA). Intragroup comparisons were performed by one-
way repeated-measures analysis of variance, followed by the post-hoc test of Holm-
Sidak, or if normality test failed, by the test of Student-Newman-Keuls. Paired sample 
Student’s  t test was used when only single comparisons were made. For comparisons 
between groups, the two-sample  Student’s  t test was used if data showed normal 
distribution, otherwise Mann- Whitney U rank sum test was used. Level of 
significance was set at p  ≤  0.05.  Data  are  presented  as  mean  ±  SEM. 
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7.13 Relevance to therapeutic and protective hypothermia 
We wanted to develop a model for accidental hypothermia that was as man-like as 
possible. Cooling would be by immersion in cold water to mimic accidental 
hypothermia. However, since all animals were deeply sedated, we found our model 
also to resemble the protocol of surface cooling in therapeutic hypothermia after 
witnessed cardiac arrest (62).  
Originally we studied effects of various dosages of DA at different temperatures 
within the framework of accidental hypothermia, but it turned out that our findings 
might also have translational value for DA administration in therapeutic hypothermia. 
As one of our aims was to compare physiological responses in the post-hypothermic 
period following rewarming from surface cooling and cooling by extracorporeal 
bypass, the model would also have similarities with the clinical practise of applying 
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8. SUMMARY OF RESULTS 
8.1 Paper 1.  
Post-hypothermic cardiac left ventricular systolic dysfunction after rewarming in 
an intact pig model 
(all referred figures in this section relate to Paper 1) 
8.1.1 Main results 
Cooling below 34°C resulted in significantly decreased cardiac contractility that 
persisted during and after rewarming. In contrast, diastolic function recovered after 
rewarming. Although mean arterial pressure (MAP) was significantly reduced in 
hypothermia, SVR increased significantly. After rewarming, SVR was significantly 
reduced compared with pre-hypothermic baseline. CO was significantly reduced 
during rewarming, but was maintained at pre-hypothermic levels after rewarming due 
to a spontaneous increase in HR. The phenomenon of cold diuresis was not 
encountered since diuresis was unaffected by temperature throughout experiments. 
 
8.1.2 More detailed account of cardiovascular function  
i) Mild hypothermia. Ees (Fig. 2B) as the sole indicator of LV contractility, increased 
significantly at 34°C, as did indexes of diastolic function, Tau (Fig. 3D.) and EDPVR 
(Fig. 3C). dP/dtmin (Fig. 3A) decreased significantly (maximal deceleration decreased). 
MAP (Fig. 4D) and Ea/Ees (Fig. 3C) decreased significantly at 34°C. All other 
hemodynamic variables were statistically unaffected by cooling to 34°C. 
ii) Immersion cooling below 34°C. Indexes of LV contractility PRSW (Fig. 2A) and 
dP/dtmax (Fig. 2D) decreased significantly during cooling below 34°C, while Ees and 
Ea/Ees (Fig. 2C) were statistically unaffected. V0 was statistically indifferent to 
moderate and severe cooling, as were EDP (Fig. 3B) and EDPVR. During cooling 
EDV, ESV (Fig. 4F) and CVP decreased, reaching statistical significance at 25°C. 
dP/dtmin was statistically reduced (absolute values decreased) in a linear pattern during 
cooling, whereas Tau increased in a pattern reciprocal to the dP/dtmin curve. CO (Fig. 
4A), HR (Fig. 4B), SV (Fig. 4C), and MAP all decreased significantly in a linear way 
below 34°C. SVRI (Fig. 4E) increased in a nearly similar pattern, reaching 
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significance at 25°C. Except for cold-induced bradycardia, no arrhythmias were 
encountered until severe hypothermia was established. 
iii) One hour steady state hypothermia at 25°C.  No PV data derived from inferior 
caval occlusions were available at this temperature. Values for dP/dtmax, dP/dtmin, CO, 
SV and HR reached their nadir during the 1h period at 25°C, while Tau reached its 
highest value, as did SVRI. 
During stable severe hypothermia sinus bradycardia and various idio-ventricular 
arrhythmias were seen. The ECG did not show atrial fibrillation nor the so called J 
wave or Osborn wave, reported as being characteristic of severe hypothermia in 
humans (127).  In 4 out of 8 pigs the phenomenon of mechanical (or pulsus) 
alternans (128) occurred; that is, a reduced SV observed on the conductance monitor 
every other heart beat in the absence of corresponding abnormalities in 
the ECG. One animal got VF that was successfully defibrillated to an organized 
rhythm during the one-hour period at 25°C. 
iiii) Immersion rewarming and the post-hypothermic period. During rewarming PRSW 
and dP/dtmax were significantly lowered when compared to corresponding temperatures 
during cooling. HR made an abrupt and significant increase during rewarming from 25 
to 30°C, and remained significantly elevated at a stable level above this temperature. 
The other variables that were reduced by cooling tended to approach corresponding 
values during rewarming in a nearly mirror image pattern. 
After rewarming PRSW, dP/dtmax, dP/dtmin , SV, MAP, EDP and SVRI remained 
significantly decreased compared to pre-hypothermic baseline values. CVP, 
EDV and ESV returned to pre-hypothermic controls. While post-hypothermic Ees was 
statistically unchanged,V0 was significantly increased after rewarming. 
Due to a significant increase in HR, post-hypothermic CO returned to within pre-
hypothermic values. Tau and EDPVR, having been increased during rewarming, 
returned to control. In all animals cardiac rhythm spontaneously returned to sinus 
rhythm and mechanical alternans disappeared during rewarming.
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8.1.3 Other variables 
Hemoglobin (Hb) concentration (Fig. 5A) showed a biphasic pattern, decreasing 
significantly during cooling and increasing significantly during severe hypothermia 
and rewarming. Oxygen content of arterial and mixed venous blood followed a pattern 
nearly synchronous with the Hb curve, increasing statistically during severe 
hypothermia. The global delivery and consumption of oxygen (DO2 and VO2, Fig. 5B, 
C) were reduced by 61 ± 4% and 68 ± 6% respectively during cooling, giving 
corresponding reductions of 4.7 ± 0.3% and 5.2 ± 0.4% per degree C. While DO2 
correlated with temperature in a linear manner, the reduction in VO2 was just about 
1% per degree C in the temperature interval between 38 and 34°C and about 7.8% per 
degree C from 34 to 25°C, reflecting that the relationship between VO2 and decrease 
in temperature took the form of a negative exponential function. 
During rewarming DO2 returned to pre-hypothermic baseline values following a mirror 
image of the pattern during cooling, while VO2 normalized in a more linear 
way than during cooling. Albumin values (Fig. 6A) decreased significantly during 
cooling and remained significantly reduced after rewarming. Significant increases in 
both troponin T (TnT, Fig. 6B) and TNF-a (Fig. 6C) serum concentrations were seen 
after rewarming, both in contrast to their own baseline values and to time matched 
controls. Serum concentrations of DA, epinephrine and nor-epinephrine were 
statistically unchanged from pre-hypothermic values throughout the experiments. 
Diuretic output was not affected by temperature throughout experiments. 
 
8.1.4 Immersion cooling and rewarming rates; temperatures and shivering 
Immersion cooling to 25°C lasted 125 ± 15 minutes giving a cooling rate of 6.8 ± 
0.7°C/h. Rewarming lasted 133 ± 6 minutes, giving a rewarming rate of 6.0 ± 0.3°C/h. 
Visible shivering took place in all pigs at the start of cooling, but subsided with 
progressive cooling and was absent at 25°C. Little, if any, shivering was observed 
during and after rewarming.
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 8.2 Paper 2 
Changes in cardiovascular effects of dopamine in response to graded 
hypothermia in vivo 
 (all referred figures and tables in this section relate to Paper 2) 
8.2.1 Main results 
DA half life (T1/2) was 5.4 ± 0.7 min at normothermia, increased to 11.6 ± 0.8 min at 
25°C, but returned to control during rewarming at 34–35°C. 
DA infusion at 25°C elevated DA plasma concentration four-fold compared to the 
same infusion rate at normothermia, leading to increased SVR not seen at 
normothermia. Also, in contrast to the DA-mediated increase in cardiac index 
observed at normothermia, high dose DA at 25°C left cardiac index unchanged despite 
a concomitant increase in HR, since stroke index SI decreased by 43%. During 
rewarming, cardiovascular effects of DA at moderate hypothermia (30 –34°C) were 
principally similar to responses during normothermia. DA administration during 
hypothermia did not blunt post-hypothermic effects of DA, nor did DA administration 
during rewarming increase the rate of rewarming.  
 
8.2.2 More detailed account of cardiovascular effects  
i) Normothermia. The dose-response relationship of DA was the same in both groups 
at normothermia. Indexes of LV contractility dP/dtmax (Fig. 2A) and PRSW (Fig. 2B) 
increased significantly with incrementing DA dosage steps. As for DA effects on 
diastolic function, dP/dtmin increased significantly at the highest DA step (Fig. 3A), and 
Tau (Fig. 3B) decreased significantly at each DA dosage increment. Both systolic and 
diastolic LV volumes (Figs. 2C and 3D), along with EDP, (Fig.3C) were significantly 
reduced at the 16 μg/kg/min DA dosage step. CI (Fig. 4A) increased significantly at 
the mid- and high-DA dosage steps due to a synchronous increase in HR (Fig. 4B), 
since SI (Fig. 4C) was mainly unaffected by DA. MAP (Fig. 4D) was unaffected by 
DA, while SVR index (SVRI) (Fig. 4E) decreased significantly at each DA dosage 
increment. CVP (Fig. 4F) decreased significantly with incrementing DA steps. 
ii) Severe hypothermia (25°C). LV dP/dtmax increased significantly in response to DA 
infusions of 8 and 16 μg/kg/min, while dP/dtmin and Tau were influenced by DA 
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identically to during the normothermic condition. Ventricular volumes, EDP and CVP 
decreased significantly at the mid- and high-DA dosage steps at 25°C. Since caval vein 
occlusions at 25°C caused no changes in PV configuration, no data for PRSW could be 
recorded at this temperature. As during normothermia, low-dose DA (4 μg/kg/min) 
reduced SVRI significantly at 25°C. However, unlike during normothermia, the high-
dose DA (16 μg/kg/ min) infused at 25°C increased SVRI significantly, and both SVRI 
and MAP were significantly elevated in the DA group compared with the saline-
treated animals. 
DA increased HR relatively more at 25°C than at normothermia (59% vs.30% in 
response to DA 16 μg/kg/min). But as a consequence of the significant lowering of SI 
during DA infusions (8 and 16 μg/kg/min), DA had no effect on CI at 25°C. Abrupt 
termination of the highdose DA infusion at 25°C caused significant reductions of SI 
and CI (data not shown). 
iii) Rewarming from 30°C to 34°C. Changes in cardiovascular variables from baseline 
at 30°C were brought about by the combination of DA infusions and rewarming in the 
DA group, while changes in the saline group resulted from rewarming solely. 
Therefore, only significant intergroup differences at the same time points after start of 
infusions could be attributed to DA effects during rewarming from 30°C. DA brought 
about significant increases in PRSW at all dosage steps, and in dP/dtmax at the medium 
and high dosage step when compared to control animals. Both EDV and ESV were 
significantly reduced by DA infusion at 16 μg/kg/min whereas dP/dtmin, Tau, and 
EDP were unaffected by DA during rewarming. While CI and HR increased 
significantly at the highest DA dosage step, SI, MAP, and SVRI were unaffected by 
DA during rewarming. 
iiii) After rewarming. There were no intergroup differences in any hemodynamic 
variable after rewarming to 38°C, except for a significantly increased CVP in animals 
treated with DA during hypothermia. There were no differences between groups in 
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8.2.3 Influence of dopamine on immersion cooling and rewarming rates 
While overall cooling and rewarming rates did not differ significantly between 
the two groups (Fig. 1), DA-treated animals rewarmed more slowly 
(0.11 ± 0.01°C/min) from 25°C to 30°C than did saline-treated animals (0.15 ± 
0.01°C/min) (p < 0.05). DA infusions did not significantly accelerate rewarming rates 
between 30 and 34°C. 
 
8.2.4 Effects of dopamine on oxygen variables at different temperatures 
DA caused a significant increase in hemoglobin beyond the hypothermia-induced 
hemoconcentration, both in severe hypothermia and during rewarming from 30°C (Fig. 
5A). Global DO2 (Fig. 5B) changed in synchrony with CI, hence DA increased DO2 in 
normothermia but had no effect on DO2 at severe hypothermia. Also, 15 min after DA 
infusion was terminated at 25°C, DO2 was significantly reduced due to reduced CI 
compared to saline controls. However, an increase in oxygen extraction from 
hemoglobin (Fig. 5D) compensated for the reduced DO2, leaving global oxygen 
consumption similar in both groups throughout the experiment (Fig. 5C). 
 
8.2.5 Effect of dopamine on diuresis at various temperatures 
Total diuresis throughout experiments as well as average diuretic output per hour did 
not differ significantly between groups. Diuretic output between measuring points was 
statistically unaffected by either temperature or DA in any group throughout 
experiments. 
 
8.2.6 Pharmacokinetics of dopamine: Plasma concentrations and half life 
At severe hypothermia, DA infusion yielded plasma concentrations 
about four times higher than at the same infusion rate in normothermia (Table 1). 
DA T1⁄∕2 was more than doubled at this temperature (from 5.5 ± 0.7 min at 38°C 
to 11.7 ± 0.8 min at 25°C) (Fig. 6). During rewarming from 30°C, as temperature 
approached 34–35°C, DA plasma concentration and T1⁄∕2 were normalized. 
Animals in the DA group had some DA remnants at the start of DA infusions at 
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25°C, 30°C, and 38°C (after rewarming), amounting to < 5% of the preceding 
concentration measured (Table 1), but without detectable hemodynamic effects. 
 
8.3 Paper 3.  
Cooling to hypothermic circulatory arrest by immersion cooling vs. 
cardiopulmonary bypass: Worse outcome in immersion cooled pigs 
 (all referred figures and tables in this section relate to Paper 3) 
8.3.1 Main results 
Survival rates 2h after completed rewarming were 4 out of 8 immersion- cooled 
animals (IMMc group) and 8 out of 8 CPB-cooled animals (CPBc group). Compared 
with animals in the CPBc group, animals in the IMMc group had significant reductions 
in CO, global delivery of oxygen, MAP and cerebral perfusion pressure during cooling 
below 25ºC as well as after weaning from CPB after rewarming. Post-hypothermic 
brain microdialysate data showed significant increased lactate/pyruvate ratio in 
immersion cooled animals compared to animals in the CPBc group.  
 
8.3.2 More detailed account of flow, pressures and oxygen variables  
i) Cooling. Except from the initial reduction in global blood flow delivered by the 
extracorporeal circuit compared with the flow generated by spontaneous circulation, 
animals in CPBc group had a significantly higher blood flow below 34ºC than IMMc 
animals (Fig. 3A). However, as Hb content was significantly lower in the CPBc group 
after initiating CPB, and throughout cooling (Fig. 4A), DO2 (Fig. 4D) was 
significantly higher in IMMc animals until 25ºC. Below 25ºC CPBc animals had 
significantly higher DO2 than IMMc animals. Global extraction of oxygen, measured 
by SvO2 (Fig. 4 B), matched variations in DO2 so that VO2 (Fig. 4E) was independent 
of DO2. Brain oxygen extraction, measured by SvjO2 , followed the pattern of  the 
SvO2 graphs, but the difference between groups was more profound for SvjO2 than for 
SvO2 at 20ºC  (Fig. 4C). MAP (Fig. 3B) declined steadily in IMMc group while SVR 
(Fig. 3C) increased throughout cooling. In CPBc group MAP stabilized after an initial 
drop at onset of CPB, while SVR was unaffected by cooling. Consequently, at 20ºC 
  8. SUMMARY OF RESULTS 
 59 
MAP was significabtly lower in the IMMc group than in the CPBc group, while the 
opposite was the case for SVR.  
During cooling ICP declined in IMMc group while it was stable in CPBc group, 
resulting in significantly higher values in the CPBc group at severe hypothermia (Fig. 
3D). However, with the decline in MAP in the IMMc group reported above, CPP in 
this group was significantly lower than in the CPBc group at 20ºC (Fig. 3E). 
ii) Rewarming. Except from initially increased SVR and Hb in IMMc group directly 
after start of rewarming by CPB, there were no intergroup differences in CPB flow, 
MAP, SVR, ICP, CPP or oxygen variables during rewarming. However, after 
rewarming was completed, just before weaning from CPB, CPP and SvjO were 
significantly higher in the CPBc group.   
iii) Post-hypothermic period. 4 of 8 animals in IMMc group died at the time of 
weaning from CPB or shortly thereafter due to apparent electro-mechanic dissociation 
as the heart had no measurable output in spite of electrical activity. In contrast, all 
animals in CPBc group survived 2h of post CPB. In order to diminish loss of statistical 
power, comparisons of variables between groups after rewarming have been made at 
the time-point directly after weaning from CPB, when five animals in IMMc group 
were still alive.  
Animals in the IMMc group had significantly lower CO, HR, MAP, CPP, SvO2, SvjO2 
and DO2 after weaning from CPB compared with CPB-cooled animals (Table 1). SV 
was significantly reduced from pre-hypothermic baseline within groups, but there was 
no inter-group post-hypothermic difference, indicating that lack of chronotropic 
response in the IMMc group caused the reduced post-hypothermic CO in this group. 
dP/dtmax and dP/dtmin were significantly reduced within IMMc group from pre-
hypothermic baseline, but post-hypothermic intergroup differences did not reach 
statistical significance. CVP and average DA dose to support the circulation (7.4 ± 1.6 
µg/kg/min in IMMc group vs 2.1 ± 1.2 µg/kg/min in CPBc group) were both significantly 
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8.3.3 Brain metabolism during cooling and rewarming 
Brain lactate and glycerol were significantly increased in both groups at the end of 
experiment, while brain glucose/lactate ratio was decreased (fig 5). At end of 
experiment brain pyruvate was significantly lower in IMMc than in CPBc group, while 
brain lactate/pyruvate ratio was significantly depressed in IMMc group compared to in 
CPBc animals.  
 
8.3.4 Biochemical variables 
Plasma albumin values decreased significantly in CPBc group after initiating CPB 
during cooling, both compared to their baseline values and against values in IMMc 
animals (Fig. 6). However, during and after rewarming the relation between groups 
was reversed; significantly higher albumin values in CPBc group at end of experiment. 
This was the only significant intergroup difference in biochemical variables at this 
time-point.  
 
8.3.5 Fluid administration rates, weight gains and organ wet/dry ratios 
Fig.7 A demonstrates that fluid volume administration rate was significantly higher 
during cooling by CPB than by immersion cooling. However, fluid administration 
rates in immersion cooled animals were significantly higher than animals in CPBc 
group during rewarming by CPB. However, no differences between groups in overall 
fluid administration rates and total body weight gain ratios were found. Post-mortem 
wet/dry organ weight ratios (Fig. 7B) showed statistically significant increased water 
content in heart and gut in IMMc group compared to CPBc group.  
 
8.3.6 Cooling/rewarming times and temperature measurements  
Fig. 2 shows that total experiment times did not differ significantly between groups 
(10h, 28 ± 7 min in IMMc and 10h, 11 ± 8 min in CPBc group). As expected, cooling 
was significantly slower in IMMc group (1 h 52 ± 10 min) compared to in CPBc group 
(52.8 ± 2.8 min, p < 0.001). But as considerable time was used for surgical preparation 
in the latter group, there was no significant time difference between groups in reaching 
cooling end-points, measured from baseline. Rewarming lasted significantly longer in 
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the IMMc group (1h 19 ± 7 min) compared to in the CPBc group (56 ± 3 min, p = 
0.007). As expected total CPB time was longer in the CPBc group (1 h 48 ± 5 min) 
compared to 1h 19 ± 7 min rewarming time in the IMMc group (p = 0.005).  
Noteworthy, surviving IMMc animals did not manage to preserve body heat after 
weaning from CPB, resulting in significantly lower temperatures than in the CPBc 
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9. DISCUSSION 
9.1 How to assess systolic and diastolic function in hypothermia? 
The view that Ees is an applicable contractility index in various pathological states 
affecting myocardial function has been challenged by Aghajani et al (116). In 
experimental normothermic heart failure, they demonstrated significant increases in 
Ees in stunning, acute myocardial ischemia and endotoxemia, despite significant 
reduction in other LV functional variables (CO, dP/dtmax and MAP) (116). The 
increase in Ees was accompanied by significant increase in V0, which resulted in 
apparently steeper Ees slopes (116).  
In Paper 1, Ees was unaffected by hypothermia at 30˚C, and showed no reduction after 
rewarming, as opposed to other indices of systolic function (PRSW, dP/dtmax SV and 
MAP) (62). Also, in concordance with the findings in experimental heart failure by 
Aghajani et al (116), we demonstrated a post-hypothermic significant increase in V0, 
possibly  resulting  in  a  “falsely”  increased  ESPVR  slope  (62).  We therefore concluded 
that Ees was an unreliable contractility index in hypothermia.  
Instead, in Paper 2 we resorted to the related index, PRSW, which had been used to 
determine  LV cardiac contractility during earlier experiments of cooling and 
rewarming and found to be a more robust index of contractility than Ees during 
hypothermia (70). As PRSW results from SW divided by EDV, it incorporates both 
systolic and diastolic function, and therefore serves as an integrated index of global 
ventricular function. Therefore, it may not be the ideal index to separate systolic from 
diastolic function, as was our aim in Paper 1. Furthermore, as pointed out in the 
Results section, PRSW (and Ees) was of no use in severe hypothermia, as VCO had no 
effect on the PV loop configuration.  
It seems that VCO-based contractility indexes alone are of limited value in 
experimental hypothermia research below 30˚C. One could argue that, in the absence 
of VCO-derived contractility data at 25°C, single beat estimates of contractility 
could have replaced traditional deloading variables. However, in vivo single beat 
contractility estimations in pig have been shown to be unreliable and no better than 
dP/dtmax in predicting LV contractility (129). 
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Therefore,  information  from  “conventional”  indices  of  myocardial  contractility  (SV,  
MAP) and non-VCO-related indices derived from the conductance catheter (dP/dtmax 
and ESV) may be synthesized to fill in the gaps of information on systolic function in 
severe hypothermia. Likewise, even if data on EDPVR may not be obtained, the 
indices dP/dtmin, Tau, LVEDP and EDV give information on diastolic function even in 
deep/severe hypothermia. 
 
9.2 Systolic,  but  not  diastolic  cardiac  failure  after  rewarming  from  25˚C   
In Paper 1 we concluded that the post-hypothermic cardiac state is characterized by 
systolic failure with maintained diastolic function. This clearly makes post-
hypothermic cardiac dysfunction different from myocardial stunning, where not only 
systolic, but also diastolic dysfunction is an invariable finding (130). 
Hypothermia-induced cardiac failure shares similarities with myocardial stunning in 
that both conditions involve intracellular Ca2+ overload which may partly be attributed 
to hypothermia-induced inhibition of the Na+/K+-ATPase in the sarcolemma, partly to 
impaired clearance of free cytosolic Ca2+. While the proposed mechanism in 
hypothermia is a temperature-dependent attenuation of ion transport mechanisms (73), 
the concept of myocardial stunning is invariably linked to the ischemia-reperfusion 
syndrome where dysfunction of ion transport mechanisms due to lack of ATP, together 
with production of reactive oxygen species, causes Ca2+ overload and alteration of 
contractile protein function (131). The post-hypothermic increase in plasma TnT in 
Paper 1, although minute in a clinical context, probably was due to Ca2+ mediated 
activation of intracellular proteases that degrade troponins in the same manner as has 
been suggested to take place during myocardial stunning (131). 
During hypothermia changes in diastolic functional variables were observed. Most 
prominent was the increase in isovolumetric relaxation, Tau, and decrease in dP/dtmin, 
indicating a temperature-dependent slowing of sarcoplasmic reticulum (SR) function 
that together with potentially elevated intracellular Ca2+concentration delayed 
clearance of cytosolic Ca2+. This finding corresponds well with the fact that diastolic 
Ca2+ extrusion depends mainly on SR Ca2+ pump activity, also during hypothermia
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(132), and that enzyme kinetics of the Ca2+ pump is highly temperature dependent (Q10 
effect). The passive, late diastolic phase, the filling phase, was less compromised 
during hypothermia as indicated by a modest increase in EDPVR in the present 
experiment. 
The effects of change in temperature on the SR Ca2+ pump are demonstrated by the 
return to control of Tau after rewarming. The post-hypothermic decrease of dP/dtmin  
may imply an early diastolic dysfunction which remained from the hypothermic 
period. However, Tau and EDPVR returned to pre-hypothermic levels, EDV was 
statistically unchanged and EDP was even reduced after rewarming. We interpret the 
post-hypothermic decrease in dP/dtmin as resulting from the concomitantly decreased 
MAP, and suggest that posthypothermic early, as well as late diastolic function is 
normalized after rewarming. This is in accordance with previous findings that diastolic 
function was restored in post-hypothermic core cooled dogs (70). 
To summarize, we propose that elevated intracellular Ca2+ concentration during 
hypothermia did cause post-hypothermic systolic failure through modification of 
contractile proteins. However, there was never a lack of ATP causing sustained 
diastolic stiffness, an aspect known of myocardial stunning. Diastolic Ca2+ extrusion 
was restored to pre-hypothermic levels in synchrony with the restoration of the highly 
temperature dependent enzyme kinetics of the Ca2+ pump. 
 
9.3 Post-hypothermic interaction between heart and vasculature  
There was no sign that the modest post-hypothermic reductions of MAP and SVR after 
immersion cooling to 25˚C affected organ blood perfusion, and since CO was 
maintained, the phenomenon of rewarming shock was not encountered. Our protocol 
of  iv  administration  of  Ringer’s  acetate  at  9  ml/kg/h  probably  prevented  hypovolemia  
during and after rewarming. In stead, post-hypothermic reductions of MAP and SVR 
could be interpreted as an adaptive measure by the organism rather than as a sign of 
incapacitation of vascular tonus control. As mentioned in chapter 5.4.6 in the 
INTRODUCTION section, the interaction between vascular tone and cardiac 
contractility is expressed through the Ea/Ees coupling ratio (60;61). Ea in itself, being 
the ratio between LVESP/SV, is not a variable solely derived from the vascular 
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system, and as such does encompass more than SVR. Effective coupling of heart to 
artery may be defined as the optimal transfer of blood from heart to periphery without 
excessive changes in blood pressure, and it has been reported that an Ea/Ees coupling 
ratio of 0.6 to 1.2 represents a near optimal relation between work and efficiency (61). 
When systolic heart failure (low Ees) is accompanied by high arterial elastance (high 
Ea), the Ea/Ees is elevated and the unfavorable situation of afterload mismatch occurs 
(61). In the present study post-hypothermic Ea/Ees was statistically unchanged from 
baseline. If MAP and SVR had remained unchanged from pre-hypothermic values, Ea 
would have been increased, possibly leading to an Ea/Ees ratio significantly increased 
in an unfavorable direction. In our opinion the reduced post-hypothermic SVR, in the 
presence of reduced LV contractility and SV, may imply an optimized arterial-
ventricular coupling ratio that together with increased HR normalizes CO and DO2. 
 
9. 4 Cooling below 25˚C: When does spontaneous circulation become 
unsustainable?  
The post-hypothermic cardiac failure after rewarming  following 1h hypothermia at 
25ºC in Paper1 was mild and well compensated. While Paper 1 relates to global 
variables, previous experiments in our group using dogs cooled to 25°C demonstrated 
the absence of myocardial oxygen or substrate deficits (70). It seems therefore that 
experimental cooling to 25°C is relatively well tolerated. However, in Paper 3, 
immersion cooled animals (IMMc group), in contrast to animals cooled by CPB (CPBc 
group), were exposed to a protracted period during cooling below 25°C, lasting from 
30 to 65 min, with continuously decreasing organ perfusion, evident as marked 
reduction in CO and MAP. Despite a higher Hb concentration in the IMMc group than 
in CPBc animals whose blood was diluted by the extracorporeal circuit, DO2 fell as a 
result of the lower CO in the IMMc group. Due to increased extraction of oxygen from 
Hb, apparent from a reduced SvO2, immersion cooled animals managed to keep global 
oxygen consumption at the same level as pigs that were maintained on CPB. However, 
it has been demonstrated that a MAP of 40 mmHg during hypothermic CPB may lead 
to cerebral ischemia, indicated, among other variables, by increased levels of lactate 
and lactate/pyruvate ratio in microdialysate fluid (133). Our finding of significantly 
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increased brain lactate in IMMc animals compared with CPBc animals at onset of HCA 
was preceded by significant drops in both MAP, CPP and SvjO2. The more than 
doubled SVR in IMMc animals compared with CPBc animals below 25°C may have 
contributed to a compromised tissue perfusion. Taken together, a core temperature of 
25°C  in  the  pigs  used  in  Paper  3  seems  to  represent  a  “breaking  point”,  below  which  
spontaneous circulation was no longer sustainable for all organ systems, even if global 
VO2 was unaffected. This parallels to observations in rats maintained at 15°C (which is 
above the temperature level where asystole is reported to occur in rat hearts) for 1 – 4 
hours (72). Although global oxygen supply was not a limiting factor during the 
ensuing rewarming (72), there was a hypothermia-induced myocardial ATP depletion 
and lactate accumulation after rewarming that could be comparable with the 
characteristics of low-flow ischemia (47).  
The  macroscopic  phenomenon  of  “stone  heart”,  or  irreversible  ischemic  contracture,  
occurred in 4 of 8 immersion cooled animals in Paper 3 during the rewarming. Before 
cardioplegic solutions and hypothermic bypass were routinely undertaken during the 
1970’s,  this  clinical  phenomenon,  later  linked  to  cytosolic  Ca2+ accumulation (134), 
was a feared complication to ischemic cardiac arrest during heart surgery (135). The 
fact  that  “stone  hearts”  were  not  encountered  during  rewarming  in  the  CPBc group, 
which also had undergone a period of 75 min of deep HCA, emphasizes the 
detrimental effects of long-lasting severe hypothermia in combination with 
unsustainable perfusion in terminal immersion cooling.  
While  animals  that  were  immersion  cooled  to  25˚C  in  Paper  1,  as  well  as  animals  that  
were cooled by CPB in Paper 3, may have adjusted to a mild post-hypothermic cardiac 
failure by increasing HR and lowering SVR while maintaining an adequate MAP, 
there were seemingly no such mechanisms present in surviving immersion cooled 
animals in Paper 3 after rewarming. Despite a CO that was reduced by nearly 50% 
compared with baseline, there was no compensatory increase HR, which was at pre-
hypothermic baseline level. Furthermore, post-hypothermic SVR was also unchanged 
from pre-hypothermic baseline, offering no relief for the failing heart. The apparent 
loss of post-hypothermic systemic cardiovascular autoregulation in animals that were 
immersion cooled to HCA raises the question whether neuronal control centres  in
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the  brain  stem  had  been  damaged  as  a  consequence  of  immersion  cooling  below  25  ˚C.   
 
9.5 Pharmacokinetics of dopamine in hypothermia 
Our finding that DA T½ was more than doubled at 25°C indicates a reduced 
clearance, but the assumed plasma reduction that is discussed further in section 9.6.2. 
probably had an additional effect due to a decrease in the apparent volume of 
distribution. 
Assuming first-order  elimination  kinetics,  a  DA  infusion  rate  of  about  4  μg/kg/min  at  
25°C  could  be  comparable  to  16  μg/kg/min  in  normothermia,  given  the  fourfold  
increase in DA plasma concentration at 25°C. During rewarming, at the temperature 
goal zone for therapeutic hypothermia, DA plasma concentration and T½ normalized, 
illuminating the difference in pharmacokinetics between severe and moderate 
hypothermia. 
There is the possibility that low temperature change kinetics from first order to zero 
order. However, our data fit nicely to a first order elimination curve, an observation 
that suggests the existence of first order elimination.      
 
9.6 Effects of dopamine in the normothermic and hypothermic pig 
9.6.1 Normothermia 
Despite similarities between man and pig in cardiovascular physiology, the present 
study disclosed differences between these species in cardiovascular effects of DA. In 
man, low-dose DA (2–4 μg/kg/min) improves renal blood flow and increases diuretic 
output through activation of DA receptors (105). This diuretic response was absent in 
our piglets, a finding also reported by other researchers (136;137). Conversely to what 
is observed in man DA did not affect SI in our pigs, but CI increased as a result of 
increased HR, a finding which is supported by others (136). While high dose DA 
(above 10 μg/kg/min) in man engages α-adrenergic receptors relatively more than at 
lower doses, leading to increased SVR (41), incrementing DA doses in normothermia 
resulted in decreasing SVR in the present study, as reported also by others (136). 
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9.6.2 Moderate hypothermia 
Earlier experimental studies have demonstrated that rewarming from severe 
hypothermia reverses hypothermia-induced plasma reduction (discussed below) 
(31;32;119). As DA pharmacokinetics normalized, it could be expected that the 
response to DA would resemble the normothermic state with increased HR, 
maintained SI, and consequently increased CI as temperature approached 34°C in 
Paper 2. 
 
9.6.3 Dopamine in severe hypothermia: Improved systolic and diastolic function, but 
no effect on cardiac output  
The  finding  that  DA  at16  μg/kg/min  at  25°C resulted in increased SVR without 
increasing CO, contrary to in the normothermic situation, is consistent with earlier 
referred reports that when epinephrine, in a dose that induced vasodilatation and 
elevated CO in normothermic rats, is administered during rewarming from 24°C, the 
result is vasoconstriction without elevation in CO (94),  and that a defined dosage of 
epinephrine given to dogs caused vasodilatation in normothermia, but increased SVR 
at 25°C (95). Therefore, the altered pharmakokinetcs and pharmacodynamics of DA 
during severe hypothermia in the present thesis may be an effect of hypothermia on 
drug effects and drug metabolism common to all catecholamines. 
It may seem like a paradox that DA seemed to improve isolated cardiac systolic and 
diastolic function in severe hypothermia, but failed to increase CO, as in normothermia 
or moderate hypothermia. 
 Would the increased SVR following high-dose DA at 25°C prevent LV systolic 
emptying and thus reduce SV? The answer is no, since systolic function obviously was 
well maintained with a DA-induced increase in dP/dtmax by 72% and a reduction in 
ESV by 48%. Also, the reduced EDV could not be explained by diastolic dysfunction, 
since dP/dtmin, Tau, and EDP were improved following DA infusion at 25°C.  
The reason why DA did not elevate CO at 25°C must, at least in part, be found in 
extracardiac physiologic properties of the circulation, which will be discussed in the 
following section. 
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9.7 Plasma volume reduction and increased blood viscosity in hypothermia. 
9.7.1 The role of cold diuresis 
The phenomenon of cold diuresis is seen in awake humans subjected to cold 
surroundings, and starts before core body temperature falls (138;139). One factor to 
explain this could be nonosmotic suppression of antidiuretic hormone (ADH) in 
response to increasing core intravascular volume caused by peripheral vasoconstriction 
(78;140).  Experiments on rats indicate that activation of alpha2-adrenergic receptors 
results in cold diuresis through inhibition of the action of ADH on renal tubuli (141).  
Cold diuresis does not necessarily occur in humans subjected to therapeutic 
hypothermia (142), possibly, among other factors, because lack of alpha2-adrenergic 
receptor stimulation due to deep sedation. In awake pigs however, cold diuresis was 
not observed (143), and it is therefore not surprising that we did not observe any cold-
induced diuresis in the anesthetized  pigs in Papers 1 and 2. That neither cold diuresis 
nor DA-induced diuresis was observed in the pigs, as opposed to in humans, is not 
solely a limitation of the present model; it may also be seen as an advantage: Plasma 
depletion in hypothermic pigs in Papers 1 and 2 has to be explained by other 
mechanisms that probably also play a role in humans. 
 
9.7.2 Mechanisms of plasma volume reduction 
Experimental surface cooling has demonstrated reduction in plasma volume while 
plasma protein concentrations have remained unaltered, which indicates a loss of 
whole plasma from the circulation (30;118;144). More than 50 years after the first 
studies on this topic were performed there is still no unifying theory to explain the 
mechanisms of this plasma loss. One hypothesis has stated that plasma volume 
probably was reduced during hypothermia because plasma was trapped in minute 
peripheral vessels from which erytrocytes were excluded (30). The findings of 
Klussmann and Lutcke in 1958 (31) and Chen and Chien in 1977 (144) also opt for the 
possibility that red blood cells together with plasma could be trapped in the 
microcirculation during surface hypothermia as they found that  hypothermia-induced 
expulsion of erytrocytes from the spleen  contributed to the increase in hematocrit 
during hypothermia. Representing an alternative hypothesis, Hammersborg et al more 
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recently  have  been preoccupied with extravasation of whole plasma as a cause for 
plasma loss in surface cooling, and that inflammation may play a part in this process 
(45;118). The differing views on the issue of plasma loss in surface cooling probably 
are not mutually exclusive, but demonstrate the complexity of fluid distribution 
between the intravascular and interstitial compartments during hypothermia.   
Whatever are the causes of this plasma loss, the process is perceived as reversible 
during and after rewarming  (119). From a clinical point of view, intravascular 
hypovolemia in victims of accidental hypothermia generally is suspected during 
rewarming, and so administration of varm intravenous fluids is recommended as part 
of the rewarming process  (78;79;82;100;145;146;147). 
The temperature-dependent fluctuations in Hb concentration throughout the 
experiment in Papers 1 and 2 could not be attributed to periodic blood loss, as bleeding 
from instrumentation was minimal and blood sampling was evenly distributed. Also, 
Hb concentration changes were unrelated to diuresis, as diuretic output was constant 
throughout experiments. More likely, changes in Hb concentration were caused by 
fluctuations in plasma volume as discussed above. Our findings of temporarily 
decreased CVP, EDV and ESV during hypothermia support the assumption that 
plasma volume was reduced in hypothermia and returned to normal during rewarming. 
 
9.7.3 Increased blood viscosity in hypothermia 
Another factor that would potentially influence intravascular flow in hypothermia is 
the viscosity of blood. Both increased hematocrit and decreased temperature is known 
to increase blood viscosity (63;64). However, blood viscosity is also highly dependent 
of the shear rate. (63;64). Shear rate is the rate of change of velocity at which one layer 
of fluid passes over an adjacent layer, and it increases in proportion with fluid flow 
and is inversely related to the vessel diameter (148). Reduction in CO, as is seen in 
hypothermia, has been assumed to be proportional with reduction in shear rate (63). 
When shear rate is reduced, blood does not behave like a Newtonian fluid (for instance 
water),  but  greater  “friction”  within  the  blood  increases  blood  viscosity.  In vitro 
experiments on human blood and in vivo experiments on dogs demonstrated that at 
25°C only part of the total blood viscosity could be attributed to increased 
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hematocrit and decreased temperature, as shear rate was found to account for a larger 
portion of the total increase in blood viscosity  (63;64). 
In sum, the most plausible explanation that DA in Paper 2 did not increase CO at 25°C 
despite seemingly improved DA-induced LV systolic and diastolic function, was 
that increased blood viscosity and reduced circulating blood volume, together  with 
DA-induced increase in HR,  precluded diastolic filling of the heart. 
 
9.8 Is there any need for inotropic support during hypothermia? 
Written guidelines for the use of inotropic medication at reduced core temperatures 
are scarce and based on a limited number of preclinical studies only (79). Still, studies 
have reported that > 50% of hypothermic patients receive inotropic drug therapy 
when treated with moderate therapeutic hypothermia (32–34°C) after resuscitation 
from cardiac arrest (101;102) or during rewarming from accidental hypothermia 
(18;54). In contrast, in patients hospitalized for acute heart failure without 
hypothermia, a subgroup of about only 10% received inotropic drugs (103). 
In animals in Papers 1 and 2, CI was reduced by 70% at 25°C. However, MAP 
remained at 50 mm Hg, there were no signs of inadequate global oxygen supply, and 
diuresis was maintained. The hypothermic injury inflicted on the animals was a mild 
post-hypothermic systolic dysfunction that was well compensated for . 
Therefore, the animals were not in need of inotropic support during or after 
hypothermia. It would have been a misinterpretation to give a vasoconstrictor 
to elevate MAP at 25°C, since the low MAP resulted from low CI and not 
from a low SVR, which was in fact increased as an effect of hypothermia . 
The infusion of high-dose DA at 25°C in Paper 2 had no effects on CI but gave the 
adverse effect by increasing SVR, thus potentially compromising organ perfusion. 
Also, abrupt termination of DA infusion at 25°C was potentially detrimental by 
inducing a temporary reduction in global oxygen supply. The slowed rewarming in 
the DA group from 25°C to 30°C in Paper 2 could also be interpreted as an adverse 
effect from high-dose DA, since the combined effect of increased SVR and decreased 
CI after DA withdrawal may have slowed heat transfer from body surface to core. 
It has been argued that inotropes in normothermic acute heart failure should 
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be applied on a short-term basis and confined to patients with a clear evidence of 
impaired organ perfusion and a low output state (149). In hypothermia, a low CO may 
perfectly match global oxygen requirements, since global oxygen requirements decline 
by about 6% per ˚C (39). To avoid excessive use of inotropic drugs in hypothermic 
patients, the balance between global delivery and consumption of oxygen, together 
with a reasonable perfusion pressure goal, should probably direct inotropic medication 
rather than normothermic flow end points. 
In clinical medicine, accidental hypothermia patients and patients in induced 
hypothermia may also suffer from septic or ischemic injuries and therefore be in need 
of inotropic support. In such settings, drugs that elevate a subnormal SVR may be 
useful, as well as agents that increase SV without causing detrimental chronotropic 
responses and/or increased myocardial oxygen consumption. While both 
norepinephrine and the calcium sensitizer levosimendan are used for these purposes 
under normothermic conditions (149;150), they are yet inadequately tested in vivo 
during hypothermic conditions. 
 
9.9 Limited effect of dopamine in severe post-hypothermic cardiac failure  
In Paper 3, DA was administered to support a dramatically failing circulation during 
and after weaning from CPB at completed rewarming. While only one animal in the 
CPBc  group received DA after weaning, all but one of surviving animals that had been 
immersion  cooled  to  HCA  were  given  DA,  at  rates  that  averaged  7.4μg/kg/min.  A  DA  
infusion  rate  of  8  μg/kg/min  resulted  in  increased  HR  and  CO,  and  a  decreased  SVR,  
after  rewarming  in  animals  that  were  immersion  cooled  to  25˚C  in  Paper  2.  None  of 
these hemodynamic effects from DA were evident in the severe post-hypothermic 
heart failure in animals in Paper 3. If one should translate to the clinical situation, 
patients displaying such a grave post-hypothermic cardiovascular failure should 
probably be supported by mechanical devices like continued CPB combined with 
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9.10 Cooling and rewarming rates and temperature afterdrop  
Animals in Papers 1 and 2, and animals in the IMMc group in Paper 3, were 
immersion cooled at a rate of about 6˚C/hour. Factors that could explain the high 
cooling rate are that shivering was attenuated since animals were deeply anesthetized, 
the animals had a relatively large surface to weight ratio, they had no insulating 
clothing, subcutaneous fat layer is minimal in the applied breeds, water temperature 
was around 5˚C, animals were partly covered with ice slush, and heat loss was by a 
combination of convection and conduction since water was circulated through an 
external heat exchanger.  In contrast, during laboratory immersion in water at 5˚C of 
adult humans wearing outdoor clothing, reduction of body core temperature to 35˚C 
takes about 1 h, which equals a cooling rate of only 2˚C/hour (151). Of course, cooling 
would be faster in open water due to heat loss from the head, but as a rule of the thumb 
it has been stated that a core body temperature drop in adults to 35˚C in outdoor 
immersion takes at least 30 minutes, even in cold water (152).  
Immersion rewarming  rate was about 6˚C/hour , which is much faster than the mean 
rewarming rate of 1.7˚C/hour reported by rewarming of hypothermic victims by forced 
air (54).   
During immersion cooling to 25˚C (Papers 1 and 2), a further temperature drop was 
prevented by emptying cold water from the tub at 26˚C during cooling, and by adding 
small amounts of hot water to the tub. In this way, the afterdrop from 26 to 25˚C was 
made an integral part of the cooling. In a clinical setting, observing a temperature drop 
in a victim after removal from cold water into warm surroundings would have been 
referred to as regular afterdrop. Experiments on volunteers that were removed from 
cold water (8˚C) have demonstrated that temperature afterdrop lasted for about 30 
minutes and amounted to be about 1˚C (86). Given good prehospital care, afterdrop 
should ideally have ceased by admission to hospital, and no further temperature fall 
should be observed after start of active rewarming, as demonstrated in the clinical 
study by Kornberger et al (54). In Papers 1 and 2 afterdrop was not observed during 
the rapid surface rewarming. 
The fact that afterdrop occurs even after circulatory arrest was demonstrated in Paper 
3, where immersion cooled animals continued to cool in all measured body 
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compartments during 75 min of HCA (Fig. 1A). In contrast, animals that were core 
cooled,  that  is  cooled  by  CPB,  had  what  may  be  called  a  temperature  “after-rise”:  
Temperature curves from all measured body compartments inclined upwards during 75 
min of HCA (Fig. 1B). 
All temperature drifting observed in animals in Papers 1-3 may be understood within 
the framework of simple thermo-dynamics, that is, transfer of heat between core and 
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10. FINAL CONCLUSIONS 
10.1 Paper 1 
 Cardiac left ventricular contractility decreases during surface cooling below 
34°C. 
 Cardiac systolic function is depressed after rewarming from 25°C. 
 Cardiac diastolic function is restored after rewarming from 25°C. 
 Post-hypothermic cardiac output is maintained by a spontaneous 
increase in heart rate. 
 Decreased post-hypothermic systemic vascular resistance may be adaptive 
measure. 
 
10.2 Paper 2 
 Pharmacokinetics of DA normalized during rewarming at moderate 
hypothermia (30 - 34˚C). Effects of DA during moderate hypothermia were 
comparable to the normothermic situation. 
 Pharmacokinetics of DA was seriously altered at severe hypothermia (25˚C). 
Even if DA improved both systolic and diastolic function, cardiac output did 
not improve since stroke volume decreased with incrementing DA dosages. 
 Increased SVR at high-dose DA at 25°C suggests vascular α-adrenergic 
involvement not seen in normothermia. 
 Properties of the low-flow, high-viscosity circulatory state, combined with 
serious alterations in the pharmacokinetics of DA, may explain the lack of 
beneficial – and potentially harmful – effects from DA administration at 25°C. 
 Administration of DA during hypothermia did not blunt post-hypothermic 
responses to DA. 
 Administration of DA during rewarming did not increase rate of rewarming. 
 Temperature-related alterations in pharmakokinetcs and effects of DA in the 
present thesis confirm similar results from testing epinephrine in other species  
and may be a common effect of hypothermia on catecholamines.  
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 Our findings support guidelines from American Heart Association (2010) and 
European Resuscitation Council (2010) to maintain an attitude of reservation 
towards administration of catecholamines if core body temperature is < 30°C 
 
10.3 Paper 3 
 Immersion cooling below 25ºC resulted in deteriorated global perfusion and 
oxygen delivery.  
 Regional ischemic damage may have taken place in the brain and other vital 
organs in the IMMc animals during immersion cooling below 25ºC .  
 Immersion cooling to deep hypothermic circulatory arrest followed by 75 min 
resulted in severe cardiovascular failure after rewarming. 
 Autoregulatory reflexes to compensate for cardiovascular failure were absent in 
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